https://www.pro.novartis.com/ru-ru/ 2026-01-27T08:10:35+00:00 daily 1.0 https://www.pro.novartis.com/ru-ru/vozvrat-k-targetnoy-terapii-u-pacientov-s-melanomoy-kozhi-koncepcii-retreatment-i-rechallenge 2025-05-13T07:11:47+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/axial-spondyloarthritis/treatment-retention-and-efficacy-of-secukinumab-in-patients-with-psoriatic-arthritis 2025-12-23T10:25:29+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/reviews/vliyanie-novoy-ili-progressiruyushchey-anemii-na-klinicheskie-ishody-u-2233-pacientov-s--mielofibrozom-na-fone-terapii-ruksolitinibom-v-issledovanii-s-rasshirennym-dostupom-jump 2025-07-28T11:38:00+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/reviews/approaches-to-the-treatment-of-patients-with-myelofibrosis 2025-07-11T11:23:26+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/reviews/response 2025-07-25T11:25:39+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/reviews/dolgosrochnie-effekti-terapii-ruksolitinibom-v-sravnenii-s-nailuchshei-dostupnoi-terapiei-u-patsientov-s-istinnoi-politsitemiei 2025-07-09T11:38:47+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/reviews/overall-survival-studies 2025-07-10T12:27:39+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/reviews/desyatiletniy-opyt-lecheniya-mielofibroza-ruksolitinibom 2025-07-31T11:11:35+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/vzaimosvyaz-mezhdu-vozrastom-priverzhennostyu-endokrinnoy-terapii-i-riskom-recidiva-u-pacientok-s-hr-her2-rannim-rmzh 2025-07-24T07:08:02+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/priobretennye-mutacii-u-pacientov-poluchavshih-ribociklib--et-ili-monoet-v-issledovaniyah-monaleesa 2025-07-24T07:16:47+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/lungcancer/information/epidemiologiya-nmrl 2025-07-31T11:53:14+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/rezultaty-issledovaniya-ribecca-effektivnost-i-bezopasnost-ribocikliba-v-lechenii-hrher2--mrmzh 2025-07-09T14:08:18+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/podgruppovoy-analiz-rossiyskoy-populyacii-v-ramkah-issledovaniya-iiib-fazy-compleement-1-sravnenie-s-obshchey-populyaciey 2025-07-17T08:12:13+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/reviews/landmark 2025-07-10T11:20:32+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/kakaya-kombinaciya-s-fulvestrantom-predpochtitelna--v-pervoy-linii-lecheniya-hrher2--mrmzh 2025-07-14T09:08:39+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/kakaya-kombinaciya-s-ia-predpochtitelna-v-pervoy-linii-lecheniya-hrher2--mrmzh 2025-07-09T14:09:20+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/obshchaya-vyzhivaemost-u-pacientok-s-hr-her2--mrmzh-v-postmenopauze-obnovlennye-dannye-monaleesa-3 2025-07-09T14:42:54+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/horizon-of-therapy-possibilities 2025-07-17T07:07:04+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/vliyanie-lecheniya-raka-molochnoy-zhelezy-na-neyrokognitivnye-sposobnosti 2025-07-31T11:47:59+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/reviews/reveal 2025-07-11T11:18:47+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/reviews/obnovlenie-nacionalnyh-klinicheskih-rekomendaciy-po-diagnostike-i-lecheniyu-ph-negativnyh-mieloproliferativnyh-novoobrazovaniy 2025-07-23T12:33:41+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/effektivnost-i-bezopasnost-ribocikliba-u-pozhilyh-pacientov-v-issledovaniyah-monaleesa-2--3-i--7 2025-07-09T14:21:35+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/effektivnost-ribocikliba-posle-1-linii-ht-u-bolnyh-s-hr-her2--mrmzh 2025-07-09T14:10:10+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/ekonomicheskoe-i-terapevticheskoe-bremya-rasprostranennogo-raka-molochnoy-zhelezy-analiz-ingibitorov-cdk46-v-rutinnoy-praktike 2025-07-17T07:18:32+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/lungcancer/information/patomorfologicheskie-osobennosti-nmrl 2025-05-28T06:44:49+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/effektivnost-ribocikliba-pri-mestnorasprostranennom-hrher2--rake-molochnoy-zhelezy 2025-07-01T14:23:05+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/lungcancer/information/molekulyarno-geneticheskaya-diagnostika-nmrl 2025-07-18T13:37:19+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/lungcancer/information/alk-nmrl 2025-07-14T06:35:25+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/ribociklib-v-pervoy-linii-u-pacientok-s-agressivnym-techeniem-hr-her2--mrmzh-subanaliz-issledovaniya-right-choice 2025-07-09T14:27:06+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/lungcancer/reviews/target-therapy 2025-07-21T06:54:39+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/rezultaty-primeneniya-ribocikliba-v-realnoy-klinicheskoy-praktike-v-rossii 2025-07-09T14:41:44+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/risk-tromboembolii-pri-terapii-ingibitorami-cdk46-metaanaliz-kontroliruemyh-issledovaniy 2025-07-17T08:09:27+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/podderzhanie-kachestva-zhizni-u-bolnyh-rakom--molochnoy-zhelezy 2025-07-14T08:37:36+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/sma/information/sma-information 2025-07-18T08:16:13+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/lungcancer/reviews/pokazateli-effektivnosti-terapii-ceritinibom 2025-05-28T12:50:54+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/lungcancer/geometry-mono-1 2025-07-11T09:45:50+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/sma/information/sma-symptoms-6-18 2025-07-14T13:15:09+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/brasileeiera 2025-07-24T07:40:33+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/lungcancer/reviews/kampatinib 2025-07-16T08:55:32+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/lungcancer/reviews/efficacy-of-capmatinib 2025-07-16T08:50:35+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/sma/information/sma-symptoms-0-6 2025-07-14T13:11:05+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/zoledronovaya-kislota 2025-07-22T10:15:06+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/posleduyushchaya-terapiya-u 2025-07-17T08:01:56+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/sma/information/sma-information/differencialnyy-diagnoz-spinalnoy-myshechnoy-atrofii 2025-07-21T09:49:45+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/povyshenie-dozy-anastrozola-dlya-optimalnogo-podavleniya-urovnya-estrogenov-pri-rannem-rmzh--v-postmenopauze-prospektivnoe-issledovanie 2025-07-23T13:16:39+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/sma/information/diagnosys-program 2025-07-18T08:17:44+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/vliyanie-vnutrennego-podtipa-na-effektivnost-terapii-ingibitorami-cdk46-pri-rasprostranennom-hrher2--rmzh 2025-07-23T13:21:27+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/terapevticheskie-oblasti/nevrologiya/spinalnaya-mishechnaya-atrofiya/informatsiya-o-zabolevanii/rasshirennii 2025-07-11T12:07:42+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/reviews/comfort-1-comfort-2 2025-07-09T11:17:20+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/kakoe-lechenie-poluchayut-v-rossii-pacientki--s-hr-her2--metastaticheskim-rmzh-v-realnoy-klinicheskoy-praktike 2025-07-14T08:24:25+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/zolotoi-standart-profilaktiki-diagnostiki-lecheniya-i-reabilitatsii-bolnikh-rmzh-2023-gormonoterapiya-mrmzh 2026-03-17T07:24:26+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/esmo-bc-2023 2025-07-14T08:23:03+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/psoriasis/materials/skrining-psoriaticheskogo-artrita-u-bolnyh-psoriazom-kak-diagnostirovat-psoriaticheskiy-artrit-na-rannem-etape 2025-12-23T09:08:23+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/psoriasis/informaciya-o-zabolevaniii/kak-diagnostirovat-psoriaticheskiy-artrit-na-rannem-etape 2025-12-23T09:08:18+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/chast-4-terapevticheskie-vozmozhnosti-pri-her2-enriched-rake-molochnoy-zhelezy-rol-cdk46-ingibitorov 2025-07-14T08:26:01+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/psoriasis/informaciya-o-zabolevaniii/molekulyarnyy-shram-psoriaza-i-vozmozhnosti-sekukinumaba 2025-12-23T09:08:21+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/reviews/adyuvantnaya-targetnaya-terapiya-u-pacientov-s-melanomoy-kozhi-iiia-stadii 2025-11-21T13:04:31+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/reviews/adyuvantnaya-targetnaya-i-immunoterapiya-effektivnost-i-vliyanie-na-organospecificheskoe-metastazirovanie-melanomy-iii-stadii 2025-11-21T13:04:30+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/psoriasis/informaciya-o-zabolevaniii/gibp-v-lechenii-psoriaza-vozmozhnosti-ingibitora-il-17a 2025-12-23T09:08:20+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/lungcancer/webinars/kruglyy-stol-chto-my-znaem-o-vozmozhnostyah-immunoonkologicheskoy-terapii-pacientov-s-rl--s-drayvernymi-narusheniyami 2025-07-24T06:51:58+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/chast-3-chto-chashche-vsego-ponimayut-pod-her2-enriched-i-chto-na-samom-dele-predstavlyaet-iz-sebya-dannyy-podtip-raka-molochnoy-zhelezy 2025-07-17T07:51:42+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/lungcancer/webinars/kruglyy-stol-mezhdisciplinarnye-aspekty-lecheniya-metastazov-v-golovnom-mozge-u-pacientov-s-karcinomoy-legkogo-s-drayvernymi-mutaciyami-rol-konsiliuma 2025-07-23T13:24:42+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/reviews/finalnye-dannye-combi-ad-rezultaty-8-letnego-nablyudeniya-za-pacientami-poluchavshimi-adyuvantnuyu-terapiyu-dabrafenibom-i-trametinibom-posle-rezekcii-melanomy-kozhi 2025-11-21T13:04:36+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/lungcancer/webinars/kruglyy-stol-ot-vpechatlyayushchih-dostizheniy-k-rutinnoy-diagnostike-i-lecheniyu-nmrl-s-redkimi-alteraciyami 2025-07-23T13:25:48+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/lungcancer/webinars/kruglyy-stol-uspeshnye-praktiki-v-lechenii-pacientov-s-rl-s-narusheniyami-v-gene-met-i-alk-translokaciyami 2025-07-23T13:23:42+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/chast-2-chto-skryvaetsya-pod-immunogistohimiey-pri-rake-molochnoy-zhelezy-i-chto-s-ney-ne-tak 2025-07-17T08:02:30+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/reviews/combi-dv-5-letnyaya-vyzhivaemost-pacientov-s-braf 2025-11-21T13:04:32+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/reviews/combi-mb 2025-11-21T13:04:34+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/chast-1-pochemu-my-eshche-ne-pobedili-rmzh-her2-enriched-podtip-i-problemy-sushchestvuyushchih-podhodov-v-klassifikacii-rmzh 2025-07-10T08:08:22+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/reviews/esmo-2022-rezultaty-combi-aplus 2025-11-21T13:04:36+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/reviews/hronicheskie-nezhelatelnye-yavleniya-pri-adyuvantnoy-immunoonkologicheskoy-terapii-melanomy-kozhi 2025-11-21T13:04:38+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/reviews/adyuvantnaya-terapiya-posle-udaleniya-melanomy-kozhi-dannye-realnoy-klinicheskoy-praktiki 2025-11-21T13:04:31+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/reviews/combi-i 2025-11-21T13:04:33+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/reviews/opczii-adyuvantnoj-terapii-pri-iii-stadii-melanomy-kozhi 2025-11-21T13:04:42+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/reviews/novosti-esmo-2023--effektivnost-lecheniya-pacientov-s-rezektabelnoy-i-metastaticheskoy-melanomoy 2025-11-21T13:04:41+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/reviews/mnogocentrovoe-issledovanie-adyuvantnoy-terapii 2025-11-21T13:04:41+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/reviews/combi-aplus 2025-11-21T13:04:32+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/reviews/troynaya-kombinaciya--opravdala-li-ozhidaniya-novaya-shema-lecheniya-metastaticheskoy-melanomy-kozhi 2025-11-21T13:04:45+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/reviews/posledovatelnost-terapii-pri-metastaticheskoy-melanome-kozhi-v-realnoy-klinicheskoy-praktike--kanada-2022 2025-11-21T13:04:43+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/reviews/vozvrat-k-targetnoy-terapii-u-pacientov-s-melanomoy-kozhi-koncepcii-retreatment-i-rechallenge 2025-11-21T13:04:46+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/reviews/metastaticheskoe-porazhenie-golovnogo-mozga-pri-melanome-kozhi 2025-11-21T13:04:40+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/comparison-of-main-patient-treatment-options 2025-11-21T13:04:22+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/reviews/effektivnost-targetnoy-terapii-u-pacientov-s-melanomoy-kozhi-s-redkimi-mutaciyami-braf 2025-11-21T13:04:35+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/reviews/kak-vyyavit-paczienta-s-vysokim-riskom-razvitiya-immunooposredovannykh-nezhelatelnykh-yavlenij 2025-11-21T13:04:39+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/reviews/s-chego-nachinat-terapiyu-metastaticheskoy-melanomy-kozhi 2025-11-21T13:04:44+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/reviews/kak-vibrat-kombinatsiyu-ingibitorov-braf-i-mek-dlya-lecheniya-patsienta-s-metastaticheskoi-melanomoi-Fokusiruemsya-na-bezopasnosti 2025-11-21T13:04:38+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/reviews/describe-2 2025-11-21T13:04:35+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/reviews/vliyanie-targetnoi-terapii-i-immunoterapii-na-kachestvo-zhizni-patsientov-s-melanomoi-kozhi 2025-11-21T13:04:45+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/reviews/korrektsiya-nezhelatelnikh-yavlenii-na-fone-terapii-kombinatsiei-dabrafenib-trametinib 2025-11-21T13:04:40+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/reviews/fokus-na-sravnenii-profilei-bezopasnosti-targetnoi-i-immunnoi-adyuvantnoi-terapii-melanomi-kozhi 2025-11-21T13:04:37+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/cases/klinicheskii-sluchai-dlitelnogo-otveta-pri-vozvrate-k-targetnoi-terapii-pri-metastaticheskoi-melanome-kozhi 2025-11-21T13:04:18+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/systemic-treatment-options-for-patients 2025-11-21T13:04:46+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/reviews/samoe-masshtabnoe-issledovanie-vozvrata-k-targetnoy-terapii-u-pacientov-s-melanomoy-kozhi-dannye-gollandskogo-reestra 2025-11-21T13:04:44+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/idiopaticheskaya-trombocitopenicheskaya-purpura 2025-07-24T07:56:14+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/axial-spondyloarthritis/vzaimosvyaz-mezhdu-tormozheniem-rentgenologicheskogo-progressirovaniya-i-dostizheniem-nizkoy-aktivnosti-zabolevaniya-ili-remissii-i-ih-osnovnymi-komponentami-u-pacientov-s-psoriaticheskim-artritom 2025-12-23T10:26:04+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/axial-spondyloarthritis/sravnenie-pokazateley-dolgosrochnoy-priverzhennosti-sekukinumabu-i-adalimumabu-s-ispolzovaniem-psevdorandomizacii-u-pacientov-s-psoriaticheskim-artritom-rezultaty-issledovaniya-flyway-v-usloviyah 2025-12-23T10:25:20+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/axial-spondyloarthritis/funkciya-neytrofilov-posle-lecheniya-pacientov-s-psoriaticheskim-artritom-sekukinumabom 2025-12-23T10:25:12+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/essential-thrombocythemia/answer-for-essential-thrombocythemia-therapy 2025-07-09T12:24:19+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/axial-spondyloarthritis/bremya-zabolevaniya 2025-12-23T10:25:09+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/axial-spondyloarthritis/sekukinumab-obespechivaet-ustoychivoe-uluchshenie-sostoyaniya-nogtey-umenshenie-simptomatiki-psoriaticheskogo-artrita-i-snizhenie-chastoty-rentgenologicheskogo-progressirovaniya-u-pacientov-s-soput 2025-12-23T10:25:19+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/axial-spondyloarthritis/targetnoe-lechenie-ingibitorami-interleykina-17-u-pacientov-so-spondiloartritom-i-svyazannym-s-nim-profilem-kardiometabolicheskogo-riska 2025-12-23T10:25:21+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/axial-spondyloarthritis/obnovlennye-rekomendacii-eular-2023--po-psoriaticheskogo-artrita 2025-12-23T10:25:15+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/axial-spondyloarthritis/vospalitelnaya-bol-v-spine 2025-12-23T10:26:03+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/axial-spondyloarthritis/otvet-na-lechenie-sinovita-pri-psoriaticheskom-artrite-sekukinumabom-rezultaty-12-nedel-terapii-v-klinicheskom-ispytanii-fazy-iii-ultimate 2025-12-23T10:25:18+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/axial-spondyloarthritis/opredelenie-aksspa-i-raznovidnosti 2025-12-23T10:25:17+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/axial-spondyloarthritis/uroven-uderzhaniya-terapii-i-effektivnost-sekukinumaba-a-takzhe-vliyanie-pereryvov-v-terapii-u-pacientov-s-aktivnym-psoriaticheskim-artritom-i-ankiloziruyushchim-spondilitom-po-dannym-issledovaniya 2025-12-23T10:26:01+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/axial-spondyloarthritis/maximise 2025-12-23T10:25:14+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/axial-spondyloarthritis/vliyaet-li-terapiya-anti-fno-a-na-progressirovanie-strukturnyh-povrezhdeniy-u-pacientov-s-ankiloziruyushchim-spondilitom 2025-12-23T10:26:01+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/axial-spondyloarthritis/terapiya 2025-12-23T10:25:49+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/axial-spondyloarthritis/bezopasnost-sekukinumaba-na-osnove-analiza-1-milliona-paciento-let-primeneniya-opyt-postmarketingovyh-issledovaniy-i-klinicheskih-ispytaniy 2025-12-23T10:25:08+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/essential-thrombocythemia/cure-for-essential-thrombocythemia 2025-07-10T13:58:28+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/essential-thrombocythemia/definition-of-essential-thrombocythemia 2025-07-09T10:27:55+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/essential-thrombocythemia/prognosis-for-essential-thrombocythemia 2025-07-09T10:30:05+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/essential-thrombocythemia/diagnosis-of-essential-thrombocythemia 2025-07-09T10:28:46+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/information/classification-of-myeloproliferative-neoplasms 2025-07-09T10:31:33+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/information/the-pathogenesis-of-myeloproliferative-neoplasms 2025-06-04T15:44:22+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/information/etiology-of-myeloproliferative-neoplasms 2025-06-04T15:54:35+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/cases/klinicheskiy-sluchay-adyuvantnoy-terapii-braf-melanomy-kozhi-s-brv-36-mesyacev 2025-11-21T13:04:19+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/istinnaya-polycythemia/cardiologists-and-therapists/secondary-prevention-of-thrombosis 2025-07-10T09:17:54+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/istinnaya-polycythemia/cardiologists-and-therapists/increase-in-hematocrit 2025-07-10T08:47:11+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/istinnaya-polycythemia/cardiologists-and-therapists/diagnosis-of-true-polycythemia 2025-07-10T08:26:44+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/protivoopuholevyy-effekt-i-kachestvo-zhizni-est-li-neobhodimost-zhertvovat-nablyudenie-ekspertov-mknc-im-as-loginova 2025-07-01T14:40:30+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/porazhenie-pecheni-pri-hr-her2--rrmzh-nablyudenie-ekspertov-nmic-onkologii-im-nn-blohina 2025-07-01T14:41:00+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/sravnenie-effektivnosti-ingibitorov-ciklin-zavisimyh-kinaz-cdk46-pri-hr-her2--rake-molochnoy-zhelezy 2025-07-14T09:46:00+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/monaleesa-7 2025-07-17T08:22:21+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/risk-recidiva-hr-her2-rmzh-v-zavisimosti-ot-urovnya-porazheniya-limfouzlov--dannye-realnoy-klinicheskoy-praktiki 2025-07-10T08:22:00+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/autovospalitelnie-zabolevaniya/information/idiopathic-arthritis-general-information 2025-12-23T10:25:03+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/chetyryohletnie-rezultaty-issledovaniya-natalee-adyuvantnaya-terapiya-ribociklibom--nsia-u-pacientov--s-rannim-hr-her2-rmzh 2025-07-14T10:27:19+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/bezopasnost-i-effektivnost-ribocikliba-v-realnoy-klinicheskoy-praktike 2025-07-17T10:06:23+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/lungcancer/information/5-year-patient-survival 2025-07-22T10:16:03+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/issledovanie-right-choice-pravilnyy-vybor-dlya-pacientov-s-agressivnym-techeniem-gormonozavisimogo-her2-negativnogo-rasprostranennogo-raka-molochnoy-zhelezy-hr-her2--rrmzh 2025-07-10T07:46:20+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/dlitelnyy-kontrol-zabolevaniya-u-pacientov-s-hr-her2--rrmzh-s-mutaciey-pik3ca-issledovaniya-bylieve-na-fone-terapii-alpelisibom 2025-07-10T07:26:02+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/metallica-issledovanie-effektivnosti-metformina-dlya-profilaktiki-giperglikemii-u-pacientov-poluchayushchih-alpelisib 2025-07-14T09:48:26+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/rol-mutacii-gena-pik3ca-v-patogeneze 2025-07-14T09:49:49+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/lungcancer/information/what-to-prescribe-to-patients 2025-07-22T10:31:15+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/lungcancer/information/dabrafenib-i-trametinib-v-realnoy-klinicheskoy-praktike 2025-07-31T11:53:42+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/effektivnost-i-bezopasnost-ribocikliba-u-molodyh-pacientok-s-rannim-hr-her2-rmzh-v-issledovanii-natalee 2025-07-14T10:06:01+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/lungcancer/reviews/svyaz-mezhdu-dostupnostyu-rezultatov-molekulyarno-geneticheskoy-diagnostiki-i-obshchey-vyzhivaemostyu-u-pacientov-s-rasprostranennym-nmrl 2025-07-01T13:37:43+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/materials/doctor-and-patient 2025-06-25T14:49:12+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/profil-perenosimosti 2025-07-14T09:57:27+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/cases/klinicheskii-sluchai-dlitelnogo-otveta-na-targetnuyu-terapiyu-pri-braf-nmrl 2025-11-21T13:04:18+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/information/informaciya-o-rake-molochnoy-zhelezy 2025-07-14T08:15:04+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/cases/klinicheskiy-sluchay-dlitelnoy-brv-pri-braf-melanome-kozhi-iiic-stadii 2025-11-21T13:04:20+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/solar-i 2025-07-14T09:59:56+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/primenenie-alpelisiba-v-lechenii-hr-her2 2025-07-17T08:25:29+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/information/korrelyaciya-potrebleniya-kletchatki-i-riska-razvitiya-rmzh 2025-07-14T08:07:00+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/information/adjuvant-radiotherapy 2025-07-14T08:16:35+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/information/perimenopauza-menopauza-i-postmenopauza 2025-07-25T11:20:08+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/information/recist-11-response 2025-07-16T14:59:07+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/frequency-of-recurrence 2025-07-14T08:02:44+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/information/patogenez-melanomy 2025-11-21T13:04:27+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/information/retesting 2025-11-21T13:04:28+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/information/dermatoskopy 2025-11-21T13:04:24+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/webinars/profilaktika-i-korrekciya-giperglikemii-voznikayushchey-na-fone-terapii-alpelisibom-vzglyad-endokrinologa%23 2025-07-10T07:15:51+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/information/osobennosti-priema-dabrafeniba-i-trametiniba 2025-11-21T13:04:26+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/information/biopsiya-storozhevogo-limfaticheskogo-uzla-pri-melanome-kozhi 2025-11-21T13:04:23+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/lungcancer/webinars/prikladnye-voprosy-diagnostiki-i-lechenia-nmrl 2025-07-16T14:47:02+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/cases/klinicheskiy-sluchay-izmeneniya-braf-statusa-pri-melanome-kozhi 2025-11-21T13:04:21+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/information/mammography-and-ductography 2025-07-14T07:11:28+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/atherosclerosis/information/cholesterol 2025-07-25T11:19:01+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/atherosclerosis/information/priverzhennost-pri-gipolipidemicheskoi-terapii 2025-07-25T11:18:09+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/lungcancer/webinars/results-of-capmatinib-use 2025-07-21T06:40:25+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/information/mrt-molochnyh-zhelez-kak-komu-i-zachem 2025-07-14T07:14:46+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/lungcancer/webinars/opyt-primeneniya-kapmatiniba-u-pacienta-s-nmrl-metex14-v-ramkah-programmy-rannego-dostupa 2025-07-14T06:41:45+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/atherosclerosis/information/programma-podderzhki-pacientov-poluchayushchih-inklisiran--lipidkontrolrf 2025-07-25T11:17:04+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/information/mehanizm-deystviya-dabrafeniba-i-trametiniba 2025-11-21T13:04:26+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/polimorbidnaya-akademiya-kompleksnyy-podhod-k-kompleksnoy-probleme/razorvat-porochnyy-krug-gospitalizaciy-pacienta--s-snnfv-realno 2025-07-24T07:28:11+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/atherosclerosis/inklisiran-vozmozhnosti-lekarstvennogo-obespecheniya 2025-07-25T11:16:17+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/polimorbidnaya-akademiya-kompleksnyy-podhod-k-kompleksnoy-probleme/polimorbidnyy-pacient-s-hsn-i-anemiey-novyy-vzglyad-na-problemu 2025-07-25T11:15:27+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/lungcancer/webinars/skrining-i-diagnostika-raka-legkogo 2025-06-27T14:02:11+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/polimorbidnaya-akademiya-kompleksnyy-podhod-k-kompleksnoy-probleme/kak-chasto-v-vashey-praktike-vstrechayutsya-pacienty--s-sochetannoy-patologiey-hsn-i-hbp 2025-07-15T08:45:16+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/atherosclerosis/primenenie-inklisirana-dlya-lecheniya-geterozigotnoy-semeynoy-giperholesterinemii 2025-07-25T11:14:38+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/lungcancer/webinars/intervyu-s-ekspertom-nezhelatelnye-yavleniya-pri-prieme-preparata-kapmatinib 2025-07-14T06:46:34+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/polimorbidnaya-akademiya-kompleksnyy-podhod-k-kompleksnoy-probleme/hsn-i-sd-est-li-vzaimosvyaz 2025-07-15T08:42:05+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/polimorbidnaya-akademiya-kompleksnyy-podhod-k-kompleksnoy-probleme/hronicheskaya-serdechnaya-nedostatochnost--narusheniya-ritma-serdca 2025-07-15T08:39:55+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/polimorbidnaya-akademiya-kompleksnyy-podhod-k-kompleksnoy-probleme/hronicheskaya-serdechnaya-nedostatochnost--infarkt-miokarda 2025-07-24T08:15:26+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/information/chto-takoe-sistema-bi-rads-i-zachem-o-ney-znat-klinicistu 2025-07-14T07:34:39+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/lungcancer/webinars/intervyu-s-ekspertom-rezultaty-issledovaniya-kapmatiniba-v-ramkah-geometry-mono-1 2025-07-25T11:13:47+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/polimorbidnaya-akademiya-kompleksnyy-podhod-k-kompleksnoy-probleme/hronicheskaya-serdechnaya-nedostatochnost--arterialnaya-gipertenziya 2025-07-24T08:15:27+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/atherosclerosis/klinicheskie-rekomendatsii-narusheniya-lipidnogo-obmena-2023-g 2025-07-25T11:12:59+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/polimorbidnaya-akademiya-kompleksnyy-podhod-k-kompleksnoy-probleme/fibrillyaciya-predserdiy-i-hsn-klyuchevye-faktory-razvitiya 2025-07-15T08:35:15+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/mehanizm-deystviya-inklizirana 2025-07-25T11:11:55+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/lipoprotein/mesto-lipoproteinaa-v-klinicheskih-rekomendaciyah 2025-07-24T08:10:19+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/lipoprotein/lipoproteina-vremya-prishlo 2025-07-24T08:13:50+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/lipoprotein/lipoproteina-kak-faktor-serdechno-sosudistogo-riska-u-pacientov-s-saharnym-diabetom-i-bez-nego-registr-mass-general-brigham-lpa 2025-07-24T08:09:23+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/information/obektivnyy-vzglyad-na-petkt-pri-opuholyah-zno-molochnyh-zhelez 2025-07-14T07:31:11+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/lipoprotein/klinicheskie-issledovaniya-i-obzory-landing/klinicheskie-issledovaniya-i-obzory-article 2025-07-24T08:11:33+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/lipoprotein/novosti-eas-2024 2025-07-24T08:08:28+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/lipoprotein/diagnostika-lipoproteinaa 2025-07-24T08:12:41+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/atherosclerosis/reviews/orion 2025-07-25T11:11:10+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/information/osobennosti-vyyavleniya-i-monitoringa-kostnyh-metastazov 2025-07-14T07:45:06+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/reviews/zagadochnyy-gnoynyy-gidradenit-chast-1-aktualnye-klassifikacii-prichiny-pozdney-diagnostiki-sovremennye-metody-diagnostiki-i-diagnosticheskie-kriterii 2025-12-23T09:10:02+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/atherosclerosis/strategii-snizheniya-urovnya-holesterina-lipoproteinov-nizkoy-plotnosti-dlya-profilaktiki-ateroskleroticheskih-serdechno-sosudistyh-zabolevaniy-fokus-na-primenenii-mirnk-napravlennyh-na-pcsk9-inklisiran 2025-07-25T11:10:19+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/informaciya-dlya-pacientov-po-lecheniyu-hsn 2025-07-25T11:09:32+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/autovospalitelnie-zabolevaniya/information/gout-general-information 2025-12-23T10:25:02+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/reviews/zagadochnyy-gnoynyy-gidradenit-chast-2-algoritm-marshrutizacii-i-preimushchestva----multidisciplinarnogo-podhoda-v-vedenii-pacientov 2025-12-23T09:09:44+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/axial-spondyloarthritis/ocenka-urovnya-uderzhaniya-terapii-sekukinumabom-u-pacientov-s-psoriaticheskim-artritom-v-mnogoprofilnoy-kogorte-realnoy-klinicheskoy-praktiki 2025-12-23T10:25:16+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/axial-spondyloarthritis/vliyanie-lecheniya-sekukinumabom-na-protyazhenii-dvuh-let-na-metabolizm-kostnoy-tkani-u-pacientov-s-rentgenologicheskim-aksialnym-spondiloartritom-rezultaty-ezhednevnoy-klinicheskoy-praktiki 2025-12-23T10:26:02+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/reviews/guide-part-3 2025-12-23T09:10:00+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/reviews/guide-part-2 2025-12-23T09:07:58+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/information/osobennosti-interpretacii-dinamiki-opuholevogo-processa-na-fone-immunoterapii 2025-07-14T07:50:37+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/istinnaya-polycythemia/dermatologam/skin-toxicity 2025-07-25T11:38:21+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/istinnaya-polycythemia/clinical-picture 2025-07-11T11:34:56+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/Inclisiran-FAQ/belok-pcsk9--vazhnaya-terapevticheskaya-mishen-v-processe-korrekcii-narusheniy-lipidnogo-obmenana-ego-deaktivaciyunaceleny-preparaty-gruppy-ingibitorov-pcsk9-alirokumab-i-evolokumab-i-mirnk-inklisiran 2025-06-17T14:55:14+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/information/tonkoigolnaya-biopsiya-vs-trepan-biopsiya 2025-07-14T07:53:36+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/istinnaya-polycythemia/dermatologam/skin-manifestations 2025-07-09T10:44:39+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/reviews/guide-part-1 2025-12-23T09:07:57+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/atherosclerosis/clinical-guidelines-that-include-inclisiran 2025-07-23T12:26:23+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/Inclisiran-FAQ/pri-usilenii-lipidsnizhayushchey-terapii-voznikaet-logichnyy-vopros-stoit-li-ozhidat-bystrogo-snizheniya-urovnya-hs-lnp-v-pervye-nedeli-ili-vazhnee-orientirovatsya-na-dolgosrochnye-rezultaty 2025-06-18T10:16:53+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/Inclisiran-FAQ/inklisiran-zarekomendoval-sebya-kak-preparat-dlya-snizheniya-urovnya-hs-lnp-no-klinicheskiy-otvet-mozhet-varirovat-chto-delat-esli-snizhenie-okazalos-nedostatochnym-ili-naoborot-slishkom-vyrazhennym 2025-06-17T14:53:36+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/Inclisiran-FAQ/inekcionnye-lipidsnizhayushchie-preparaty-rasshiryayut-vozmozhnosti-terapii-dislipidemii-no-chto-luchshe--provodit-inekciyu-v-medicinskoy-organizacii-pod-kontrolem-specialistov-ili 2025-06-17T14:52:53+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/Inclisiran-FAQ/preparaty-vozdeystvuyushchie-na-belok-pcsk9-stali-revolyuciey-v-lipidologii-no-kak-imenno-oni-rabotayut-pochemu-podavlenie-pcsk9-privodit-k-bolee-effektivnomu-snizheniyu-lpnp-i-chem-etot-mehanizm 2025-06-17T14:51:54+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/Inclisiran-FAQ/lipidsnizhayushchaya-terapiya--ne-prosto-cifry-v-analizah-a-klyuchevoy-faktor-profilaktiki-serdechno-sosudistyh-sobytiy-chto-proizoydet-esli-otmenit-inklisiran-kak-bystro-izmenitsya-uroven-hs-lnp 2025-06-17T14:51:01+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/Inclisiran-FAQ/statiny-v-maksimalnyh-dozah-v-kombinacii-s-ezetimibom-pozvolyayut-mnogim-pacientam-dostich-celevogo-urovnya-hs-lnp-no-chto-delat-esli-etoy-terapii-nedostatochno-kakovy-klinicheskie-pokazaniya 2025-06-17T14:50:09+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/Inclisiran-FAQ/v-klinicheskih-issledovaniyah-lipidsnizhayushchih-preparatov-zhestkie-konechnye-tochki-tradicionno-schitayutsya-klyuchevymi-no-vsegda-li-ih-otsutstvie-oznachaet-nedostatochnuyu-dokazatelnost-terapii 2025-06-17T14:48:49+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/Inclisiran-FAQ/pri-smene-terapii-s-ingibitorov-pcsk9-na-inklisiran-u-nekotoryh-pacientov-nablyudaetsya-vremennoe-povyshenie-urovnya-hs-lnp-chem-obuslovlen-etot-effekt-vliyaet-li-na-dolgosrochnye-rezultaty-lecheniya 2025-06-17T14:41:44+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/Inclisiran-FAQ/vopros-bezopasnosti-novyh-terapiy-i-terapevticheskih-resheniy-ostaetsya-klyuchevym-pri-ih-vnedrenii-v-klinicheskuyu-praktiku-stoit-li-opasatsya-nezhelatelnyh-yavleniy-pri-dolgosrochnom-primenenii-innovacionny 2025-06-17T14:34:29+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/Inclisiran-FAQ/dolgosrochnaya-effektivnost-gipolipidemicheskoy-terapii--odin-iz-klyuchevyh-voprosov-klinicheskoy-praktiki-mozhno-li-so-vremenem-ozhidat-snizheniya-otveta-na-terapiyu-inklisiranom 2025-06-17T14:32:59+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/Inclisiran-FAQ/ateroskleroz-ostaetsya-vedushchey-prichinoy-serdechno-sosudistyh-zabolevaniy-i-fatalnyh-sobytiy-no-chto-esli-ego-mozhno-ne-prosto-lechit-a-predotvratit-s-pomoshchyu-vakciny 2025-06-17T14:26:57+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/information/uzi-pri-zabolevanii-molochnyh-zhelez 2025-07-14T07:03:25+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/atherosclerosis/mekhanizm-deistviya-malikh-interfiriruyushchikh-rnk/technology 2025-07-09T08:43:52+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/atherosclerosis/experts-opinion/tekushchie-podhody-ih-pereosmyslenie-i-innovacii-v-lipidsnizhayushchey-terapii 2025-06-11T08:59:29+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/ehokg/fenotipy-hsn 2025-08-01T13:39:49+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/ehokg/frakciya-vybrosa 2025-07-25T11:05:49+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/ehokg/globalnaya-i-lokalnaya-sokratimost-miokarda 2025-07-25T11:05:18+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/hsn/obnovlennye-rekomendacii-amerikanskoy-kollegii-kardiologov-po-vedeniyu-pacientov-s-snnfv-chto-vazhno-znat 2025-07-15T07:58:36+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/ehokg/istoriya-odnogo-paroksizma-klinicheskiy-sluchay 2025-07-25T11:04:48+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/ehokg/kak-podgotovitsya-k-ehokg 2025-07-25T11:04:16+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/ehokg/levoe-predserdie 2025-07-25T11:03:41+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/ehokg/mitralnaya-regurgitaciya 2025-07-25T11:03:09+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/webinars/ozhidaniya-vs-realnost-triplet-v-lechenii-braf-metastaticheskoy-melanomy 2025-11-21T13:04:50+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/webinars/pervaya-liniya-terapii-braf-melanomy-kozhi-ot-klinicheskih-dannyh-k-osoznannomu-vyboru 2025-08-06T08:43:54+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/ehokg/na-primere-ehokardiogrammy-pacientov 2025-07-25T11:02:35+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/webinars/rechallenge-pochemu-i-kak-rabotaet 2025-08-06T08:44:17+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/ehokg/obemnaya-peregruzka 2025-07-25T11:01:23+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/webinars/izmenenie-braf-statusa-pri-melanome-kozhi-pravda-ili-mif 2025-11-21T13:04:48+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/webinars/chto-krome-effektivnosti-vazhno-pri-vibore-adyuvantnoi-terapii-melanomi-kozhi 2025-11-21T13:04:47+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/ehokg/odsn 2025-07-24T07:50:28+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/ehokg/odsn-na-ehokg 2025-07-24T07:52:02+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/webinars/kak-pravilno-vibrat-adyuvantnuyu-terapiyu-braf-melanomi-kozhi 2025-11-21T13:04:49+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/ehokg/sistema-natriyureticheskih-peptidov 2025-07-25T11:00:10+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/ehokg/stress-test 2025-07-25T10:58:55+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/endokrinologiya/saharnyy-diabet/reviews/3-pochemu-startovaya-kombinirovannaya-terapiya-v-issledovanii-verify-sostoyala-iz-metformina-i-predstavitelya-klassa-ingibitorov-dipeptidilpeptidazy-4-idpp-4--vildagliptina 2026-03-11T13:47:40+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/pulmonologiya/five-stages-of-asthma 2026-03-11T13:33:13+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/inklisiran-prakticheskoe-rukovodstvo 2025-07-25T10:57:34+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/endokrinologiya/saharnyy-diabet/reviews/4-issledovanie-verify-znachimoe-issledovanie-glikemicheskogo-kontrolya 2026-03-11T13:47:40+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/endokrinologiya/saharnyy-diabet/reviews/1-poetapnaya-intensifikaciya-terapii-v-rekomendaciyah-proshlyh-let 2026-03-11T13:47:38+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/llo/outpatient-stage 2025-07-25T10:55:46+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/llo/main-aspects 2025-07-25T10:54:02+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/llo/inpatient_stage 2025-07-25T10:52:14+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/lipoprotein/biblioteka-video/shema-stroeniya-chasticy-lp-a-kuharchuk-vv 2025-07-24T08:16:51+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/lipoprotein/biblioteka-video/lipoprotein-a-ahmedzhanov-n-m 2025-07-24T08:15:45+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/atherosclerosis/clinical-case/clinical-case-1 2026-02-24T07:27:50+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/hsn/remodelirovanie-miokarda-pri-hsn/mehanizm-deystviya-nup 2025-07-25T10:49:20+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/endokrinologiya/saharnyy-diabet/reviews/2-rannyaya-kombinirovannaya-terapiya-v-sovremennyh-rekomendaciyah 2026-03-11T13:47:39+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/atherosclerosis/clinical-case/clinical-case-2 2026-02-24T07:27:53+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/yuvenilnyy-idiopaticheskiy-artrit/poleznye-materialy/klinicheskoe-issledovanie-sekukinumab 2025-12-23T10:27:29+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/nefrologiya/c3-glomerulopatiya/na-chto-stoit-obratit-vnimanie-u-pacienta-s-c3-glomerulopatiey 2026-03-17T10:22:51+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/yuvenilnyy-idiopaticheskiy-artrit/poleznye-materialy/yuvenilnyy-psoriaticheskiy-artrit 2025-12-23T10:27:32+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/mezhdunarodnyy-onkologicheskiy-forum-belye-nochi 2025-07-14T08:40:43+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/hsn/clinical-case-1 2025-06-16T10:26:57+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/yuvenilnyy-idiopaticheskiy-artrit/poleznye-materialy/entezit-associirovannyy-artrit 2025-12-23T10:27:28+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/hsn/clinical-case-4 2025-06-16T10:44:25+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/nefrologiya/terapiya/snizhenie-proteinurii--marker-effektivnosti-terapii-patologii-pochek 2026-03-17T10:56:26+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/hsn/clinical-case-2 2025-06-16T10:50:11+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/hsn/clinical-case-3 2025-06-17T11:41:34+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/hsn/clinical-case-5 2025-07-24T08:07:15+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/atherosclerosis/clinical-case/clinical-case-3 2026-02-24T07:27:54+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/nefrologiya/aktualnye-voprosy/rol-sistemy-komplementa-pri-zabolevaniyah-pochek-dannye-2024-goda-rezolyuciya-kdigo 2026-03-17T09:52:42+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/detskiy-psoriaz/poleznye-materialy/klinicheskoe-issledovanie-sekukinumab 2025-12-23T09:07:39+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/atherosclerosis/clinical-case/clinical-case-4 2026-02-24T07:27:57+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/information/risk-factors 2025-11-21T13:04:28+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/atherosclerosis/clinical-case/clinical-case-5 2026-02-24T07:27:58+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/information/klassifikatsiya-melanomi 2025-11-21T13:04:25+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/information/podgotovka-obrazcov-k-molekulyarno-geneticheskomu-issledovaniyu 2025-11-21T13:04:27+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/nefrologiya/terapiya/vakcinaciya-pacientov-s-patologiey-pochek-na-chto-sleduet-obratit-vnimanie-vrachu 2026-03-17T10:56:27+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/nefrologiya/terapiya/rol-nefrologa-v-prodlenii-zhizni-pacienta-s-hbp 2026-03-17T10:56:23+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/nefrologiya/aktualnye-voprosy/obnovlennye-klinicheskie-rekomendacii-po-diagnostike-i-lecheniyu-hbp-kdigo-2024-chto-izmenilos 2026-03-17T09:52:43+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/autovospalitelnie-zabolevaniya/information/adult-stills-disease 2025-12-23T10:25:01+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/nefrologiya/aktualnye-voprosy/wcn-and-era-2024 2026-03-17T09:52:45+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/nefrologiya/diagnostika/immunoperoksidaznyy-analiz-ili-immunoflyuorescenciya-kakoy-metod-bolee-dostoveren-dlya-interpretacii-pochechnoy-biopsii 2026-03-17T10:32:37+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/nefrologiya/diagnostika/vtorichnaya-biopsiya-pochek-kogda-bez-nee-ne-oboytis 2026-03-31T06:43:33+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/nefrologiya/diagnostika/biopsiya-pochki-v-praktike-vracha-nefrologa-na-chto-obratit-vnimanie 2026-03-17T11:09:26+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/nefrologiya/terapiya/komplement-blokiruyushchaya-terapiya-mesto-i-perspektivy-v-nefrologii 2026-03-17T10:56:27+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/reviews/vliyanie-rannego-nachala-terapii-na-prognoz-pri-mielofibroze-mf-obedinennii-analiz-issledovanii-comfort-i-comfort 2025-07-09T11:53:49+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/nefrologiya/diagnostika/kakoy-metod-issledovaniya-bioptatov-pochki-yavlyaetsya-bolee-informativnym-svetovaya-immunoflyuorescentnaya-ili-elektronnaya-mikroskopiya 2026-03-17T10:32:37+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/reviews/majic-pv 2025-07-11T10:51:39+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/terapevticheskie-oblasti/gematologiia/mieloproliferativnye-zabolevaniia/biblioteka-klinicheskikh-sluchaev/otvet-na-terapiyu-ruksolitinibom-u-patsienta-s-mielofibrozom-v-iskhode-istinnoi-politsitemii 2025-07-09T11:53:58+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/biblioteka-klinicheskikh-sluchaev/lechenie-gidroksikarbamidom-patsienta-s-istinnoi-politsitemiei-s-visokim-riskom-tromboticheskikh-oslozhnenii 2025-07-25T09:58:17+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/nefrologiya/nedelya-pochki-asn-2024-aktualno-interesno-vazhno 2025-12-16T12:50:43+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/lungcancer/information/braf-nmrl 2025-07-22T10:23:42+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/terapevticheskie-oblasti/cardiologia/ateroskleroz/semeinaya-giperholesterinemia-chto-delat-esli 2025-07-09T08:36:57+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/lungcancer/reviews/novosti-esmo-2024-kak-lechat-braf-nmrl-v-italii 2025-07-23T13:10:02+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/biblioteka-klinicheskikh-sluchaev/pozdnyaya-diagnostika-pervichnogo-mielofibroza 2025-07-09T12:05:45+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/biblioteka-klinicheskikh-sluchaev/primenenie-ruksolitiniba-dlya-lecheniya-pervichnogo-mielofibroza-so-znachitelnoy-splenomegaliey 2025-07-09T12:36:53+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/mesto-ribocikliba-v-obnovlennyh-algoritmah-lecheniya-2024 2025-07-23T13:03:58+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/bezopasnost-ribocikliba-i-palbocikliba-u-pozhilyh-pacientov-s-metastaticheskim-rakom-molochnoy-zhelezy-dannye-realnoy-klinicheskoy-praktiki 2025-07-16T15:15:36+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/nefrologiya/diagnostika/antitela-k-faktoram-komplementa-i-molekulyarno-geneticheskiy-skrining-na-mutacii 2026-03-17T10:32:37+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/nefrologiya/c3-glomerulopatiya/s3--glomerulopatiya 2026-03-17T10:22:53+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/nefrologiya/iga-nefropatiya/iga-nefropatiya-video 2026-03-17T10:25:14+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/essential-thrombocythemia/questionnaires 2025-07-09T10:30:51+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/nefrologiya/biblioteka-video/alternativnyy-put-aktivacii-komplementa 2025-12-16T12:53:32+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/istinnaya-polycythemia/resources 2025-07-11T11:42:04+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/RUSSKO-RMZh-2023-simpozium-Novartis-Agressivnoe-techenie-HR-HER2-mRMZh-tsvet-nadezhdii 2025-06-20T08:16:58+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/yuvenilnyy-idiopaticheskiy-artrit/poleznye-materialy/metody-ocenki-zabolevaniya-yuia 2026-02-12T09:58:19+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/zemlya-ploskaya-ili-kak-nashi-ubezhdeniya-iz-detstva-vliyayut-na-nas 2025-07-14T09:47:05+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/congresses/white-nights-2023 2025-07-16T08:17:46+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/nefrologiya/iga-nefropatiya/iga-nefropatiya-o-chem-stoit-pomnit-vrachu-nefrologu 2026-03-17T10:25:11+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/yuvenilnyy-idiopaticheskiy-artrit/poleznye-materialy-dlya-vrachey 2026-03-06T10:35:55+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/congresses/white-nights-2025 2025-07-28T11:33:01+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/yuvenilnyy-idiopaticheskiy-artrit/poleznye-materialy-dlya-pacientov 2026-02-27T12:52:08+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/detskiy-psoriaz/poleznye-materialy/interesnye-materialy 2025-07-24T20:30:42+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/detskiy-psoriaz/poleznye-materialy/metody-ocenki-zabolevaniya 2025-07-24T20:29:55+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/pro-balans/stati-o-mentalnom-zdorove/kak-podderzhat 2025-07-17T09:57:49+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/yuvenilnyy-idiopaticheskiy-artrit/videomaterialy/pravila-vedeniya-pacientov-s-eaa/algoritm-lecheniya-eaa 2026-02-17T14:02:21+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/pro-balans/serial-govoryat-na-yuridicheskom/rodstvenniki-pacienta-na-prieme 2025-07-28T07:59:02+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/yuvenilnyy-idiopaticheskiy-artrit/videomaterialy/pravila-vedeniya-pacientov-s-eaa/pervichnyy-osmotr-pacienta-eaa 2026-02-17T14:03:15+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/yuvenilnyy-idiopaticheskiy-artrit/videomaterialy/pravila-vedeniya-pacientov-s-eaa/monitoring-detey-s-eaa 2026-02-17T14:02:30+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/pro-balans/serial-govoryat-na-yuridicheskom/napravit-ili-ne-napravit 2025-07-28T07:57:08+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/pro-balans/stati-o-mentalnom-zdorove/kak-spravitsya-s-negativnymi-myslyami 2025-07-24T20:28:25+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/pro-balans/serial-govoryat-na-yuridicheskom/vrachebnaya-tayna-pacienta 2025-07-28T07:55:33+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/yuvenilnyy-idiopaticheskiy-artrit/videomaterialy/pravila-vedeniya-pacientov-s-eaa/differencialnaya-diagnostika-eaa 2026-02-17T14:02:55+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/pro-balans/serial-govoryat-na-yuridicheskom/lechebnyy-treugolnik-pacient-opekun-vrach 2025-07-28T07:29:10+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/yuvenilnyy-idiopaticheskiy-artrit/videomaterialy/pravila-vedeniya-pacientov-s-eaa/kak-razgovarivat-s-roditelyami-pri-naznachenii-gibp 2026-02-17T14:03:04+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/yuvenilnyy-idiopaticheskiy-artrit/videomaterialy/pravila-vedeniya-pacientov-s-yupsa/differencialnaya-diagnostika-yupsa 2026-02-17T14:03:00+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/yuvenilnyy-idiopaticheskiy-artrit/videomaterialy/pravila-vedeniya-pacientov-s-yupsa/algoritm-lecheniya-yupsa 2026-02-17T14:02:47+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/yuvenilnyy-idiopaticheskiy-artrit/videomaterialy/sprosi-u-revmatologa/diagnostika-entezit-associirovannogo-artrita-u-detey 2026-02-17T14:02:15+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/yuvenilnyy-idiopaticheskiy-artrit/videomaterialy/pravila-vedeniya-pacientov-s-yupsa/pervichnyy-osmotr-pacienta-yupsa 2026-02-17T14:02:28+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/yuvenilnyy-idiopaticheskiy-artrit/videomaterialy/sprosi-u-revmatologa/gde-i-kak-vyyavlyat-entezity 2026-02-17T14:02:16+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/yuvenilnyy-idiopaticheskiy-artrit/videomaterialy/pravila-vedeniya-pacientov-s-yupsa/monitoring-detey-s-yupsa 2026-02-17T14:02:45+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/pro-balans/stati-o-mentalnom-zdorove/chto-takoe-cirkadnye-ritmy-i-zachem-oni-nuzhny 2025-07-24T20:24:17+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/yuvenilnyy-idiopaticheskiy-artrit/videomaterialy/sprosi-u-revmatologa/kak-zapodozrit-eaa-osobennosti-vyyavleniya-zhalob-i-anamneza 2026-02-17T14:02:17+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/yuvenilnyy-idiopaticheskiy-artrit/videomaterialy/sprosi-u-revmatologa/ocenka-aktivnosti-eaa-i-effektivnosti-lecheniya 2026-02-17T14:02:17+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/yuvenilnyy-idiopaticheskiy-artrit/videomaterialy/sprosi-u-revmatologa/porazhenie-pozvonochnika-pri-eaa 2026-02-17T14:02:18+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/yuvenilnyy-idiopaticheskiy-artrit/videomaterialy/sprosi-u-revmatologa/marshrutizaciya-i-vozmozhnosti-obespecheniya-pacientov-s-yuia 2026-02-17T14:02:35+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/yuvenilnyy-idiopaticheskiy-artrit/videomaterialy/metody-instrumentalnoy-diagnostiki/diagnostika-yua-kistey-u-podrostkov 2026-02-17T14:03:09+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/yuvenilnyy-idiopaticheskiy-artrit/videomaterialy/sprosi-u-revmatologa/vzglyad-revmatologa-uzi-i-mrt-diagnostika 2026-02-17T14:02:50+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/detskiy-psoriaz/video/pravila-vedeniya-malenkogo-pacienta-s--psoriazom/algoritm-lecheniya-fokus-na-srednetyazhelyy-i-tyazhelyy-pso 2025-07-28T11:30:33+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/detskiy-psoriaz/video/pravila-vedeniya-malenkogo-pacienta-s--psoriazom/differencialnaya-diagnostika-kak-otlichit-pso-ot-drugih-dermatozov 2025-07-28T11:29:48+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/detskiy-psoriaz/video/pravila-vedeniya-malenkogo-pacienta-s--psoriazom/kak-pravilno-razgovarivat-s-roditelyami-pri-naznachenii-gibp 2025-07-28T11:28:53+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/yuvenilnyy-idiopaticheskiy-artrit/videomaterialy/metody-instrumentalnoy-diagnostiki/rentgenologicheskaya-i-mrt-diagnostika-eaa 2026-02-17T14:03:11+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/detskiy-psoriaz/video/pravila-vedeniya-malenkogo-pacienta-s--psoriazom/monitoring-detey-s-pso 2025-07-28T11:27:52+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/yuvenilnyy-idiopaticheskiy-artrit/videomaterialy/metody-instrumentalnoy-diagnostiki/diagnostika-porazheniya-osevogo-skeleta-pri-yuspa 2026-02-17T14:03:12+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/yuvenilnyy-idiopaticheskiy-artrit/videomaterialy/metody-instrumentalnoy-diagnostiki/diagnostika-yua-kistey-u-detey-do-12-let 2026-02-17T14:03:13+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/detskiy-psoriaz/video/pravila-vedeniya-malenkogo-pacienta-s--psoriazom/pervichnyy-osmotr-pacienta 2025-07-28T11:26:32+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/yuvenilnyy-idiopaticheskiy-artrit/videomaterialy/metody-instrumentalnoy-diagnostiki/osnovy-metoda-uzi-diagnostiki 2026-02-17T14:02:19+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/yuvenilnyy-idiopaticheskiy-artrit/videomaterialy/metody-instrumentalnoy-diagnostiki/osobennosti-uz-issledovaniya-u-detey 2026-02-17T14:02:20+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/detskiy-psoriaz/video/sovety-psihologa-kak-obshchatsya-s-roditelyami-i-malenkimi-pacientami/psoriaz-u-detey-sovety-psihologa-chast-1 2025-07-24T20:23:25+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/detskiy-psoriaz/video/sprosi-u-dermatologa/klassifikaciya-klinicheskih-form-psoriaza 2025-07-24T20:22:45+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/pro-balans/stati-o-mentalnom-zdorove/rabota-s-myslyami-kak-uspokoitsya 2025-07-24T20:22:16+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/detskiy-psoriaz/video/sovety-psihologa-kak-obshchatsya-s-roditelyami-i-malenkimi-pacientami/psoriaz-u-detey-sovety-psihologa-chast-2 2025-07-24T20:21:30+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/detskiy-psoriaz/video/sovety-psihologa-kak-obshchatsya-s-roditelyami-i-malenkimi-pacientami/psoriaz-u-detey-sovety-psihologa-chast-3 2025-07-25T09:49:47+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/detskiy-psoriaz/video/sovety-psihologa-kak-obshchatsya-s-roditelyami-i-malenkimi-pacientami/psoriaz-u-detey-sovety-psihologa-chast-4 2025-07-24T20:19:56+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/detskiy-psoriaz/video/sprosi-u-dermatologa/podgotovka-k-nachalu-gibp 2025-07-24T20:19:12+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/detskiy-psoriaz/video/sovety-psihologa-kak-obshchatsya-s-roditelyami-i-malenkimi-pacientami/psoriaz-u-detey-sovety-psihologa-chast-5 2025-07-24T20:18:38+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/detskiy-psoriaz/video/sovety-psihologa-kak-obshchatsya-s-roditelyami-i-malenkimi-pacientami/psoriaz-u-detey-sovety-psihologa-chast-6 2025-07-24T20:17:04+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/pro-balans/stati-o-mentalnom-zdorove/panicheskie-ataki 2025-07-24T20:17:52+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/detskiy-psoriaz/poleznye-materialy/klinicheskie-rekomendacii 2025-12-23T09:05:55+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis/articles/proekt-klinicheskih-rekomendaciy-2024--naznachenie-i-smena-pitrs 2025-09-22T14:13:10+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis/articles/kongress-aan-2024-6-letnie-dannye-po-ofatumumabu 2025-09-22T14:13:31+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/pro-balans/stati-o-mentalnom-zdorove/ergonomika-prostranstva-chto-govorit-o-vas-rabochee-mesto 2025-07-24T20:11:59+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis/articles/dolgosrochnoe-primenenie-pitrs-riski-zlokachestvennyh-novoobrazovaniy 2025-07-21T10:56:40+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/pro-balans/stati-o-mentalnom-zdorove/vosem-koping-strategiy-naydite-svoyu 2025-07-24T20:10:05+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/pro-balans/stati-o-mentalnom-zdorove/kineziologiechskie-priemy-i-rabota-s-telom 2025-07-24T20:11:09+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis/articles/proekt-klinicheskih-rekomendaciy-2024-techenie-rs-i-otvet-na-pitrs 2025-07-24T07:38:32+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/biblioteka-klinicheskikh-sluchaev/standard-cytoreductive-therapy 2025-07-24T20:09:03+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/pro-balans/stati-o-mentalnom-zdorove/meditacii 2025-07-24T20:06:48+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/terapevticheskie-oblasti/gematologiya/mieloproliferativnie-zabolevaniya/biblioteka-klinicheskikh-2 2025-07-24T20:05:49+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/hronicheskiy-mieloleykoz/video/bcr-abl1 2025-07-24T20:03:04+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/hronicheskiy-mieloleykoz/issledovanie-ascembl-analiz-effektivnosti-i-bezopasnosti-primeneniya-asciminiba-u-pacientov-s-hml-hf-poluchavshih-ranee-kak-minimum-2-itk 2025-07-23T14:17:21+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis/articles/rasseyannyj-skleroz-russia-questions 2025-07-22T10:40:06+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/pro-balans/sekrety-effektivnogo-upravleniya-vremenem-kak-vrachu-vystroit-grafik-tak-chtoby-vse-uspevat 2025-07-24T20:00:08+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/pro-balans/tolko-sprosit/kak-borotsya-s-vygoraniem 2025-07-28T07:54:17+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/pro-balans/tolko-sprosit/kak-okazat-psihologicheskuyu-pomoshch-pacientu 2025-07-28T07:53:36+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis/articles/rasseyannyj-skleroz-comparison 2025-07-22T10:43:43+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/pro-balans/tolko-sprosit/kak-nauchitsya-proyavlyat-emocii 2025-08-01T10:59:47+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/pro-balans/tolko-sprosit/chto-takoe-vnutrennyaya-kartina-bolezni 2025-07-28T07:53:06+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis/articles/treatment 2025-09-22T14:16:43+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis-main/dr-hauser/asclepios-dizayn-issledovaniya 2025-09-24T12:21:46+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis-main/dr-hauser/asclepios-dostizhenie-neda3-vyvody 2025-09-24T12:20:26+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis-main/dr-hauser/dannye-po-bezopasnosti-po-rezultatam-issledovaniya-asclepios-i-alithios 2025-09-24T12:15:50+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/pro-balans/tolko-sprosit/kak-soobshchit-diagnoz-pacientu 2025-07-28T07:52:15+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis-main/dr-hauser/mehanizm-deystviya-ofatumumaba 2025-09-24T11:43:34+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis-main/dr-hauser/iz-istorii-terapii-rs 2025-09-24T11:46:15+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis-main/dr-hauser/o-roli-v-kletok-v-patologii-rasseyannogo-skleroza 2025-09-24T11:42:09+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis-main/dr-hauser/asclepios-vtorichnye-konechnye-tochki-vliyanie-na-progressirovanie 2025-09-24T12:24:39+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/pro-balans/tolko-sprosit/kak-borotsya-s-agressiey 2025-07-28T07:51:45+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis-main/dr-hauser/asclepios-vtorichnye-konechnye-tochki-izmeneniya-na-mrt 2025-09-24T12:23:18+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis-main/dr-hauser/asclepios-pervichnaya-konechnaya-tochka-scho 2025-09-24T12:18:53+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/webinars/vozmozhnosti-vzaimodeystviya 2025-07-28T07:49:42+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/pro-balans/tolko-sprosit/kak-sobshchit-pacientu-o-perevode-na-palliativ 2025-07-28T07:51:07+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis-main/dr-hauser/ob-issledovanii-asclepios-i-ego-znachenii 2025-09-24T11:40:43+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/rezultaty-issledovaniya-kachestva-zhizni-pacientov-s-mpn 2025-07-28T07:49:18+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis/siponimod-video/factors 2025-10-16T13:20:42+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/pro-balans/tolko-sprosit/kak-vzaimodeystvovat-s-pacientom-effektivno 2025-07-25T11:32:19+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/pro-balans/tolko-sprosit/kak-razvit-stressoustoichivost 2025-07-25T11:29:35+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/webinars/risk-adaptirovannaya-terapiya 2025-07-25T11:30:46+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis/siponimod-video/increased-disability 2025-10-16T13:21:55+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/pro-balans/tolko-sprosit/kak-nauchitsya-taym-menedzhmentu 2025-07-25T11:28:17+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/pro-balans/tolko-sprosit/kogda-pacientu-nuzhen-psihiatr 2025-07-28T09:53:47+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis/siponimod-video/how-much-patients 2025-10-16T13:22:50+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/webinars/dannye-oprosa-regionov 2025-07-28T09:52:38+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/pro-balans/tolko-sprosit/kak-nauchitsya-oratorskomu-iskusstvu 2025-07-28T09:51:33+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/pro-balans/tolko-sprosit/gde-nayti-resursy 2025-07-28T09:47:17+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis/siponimod-video/real-clinical-practice 2025-10-16T13:24:01+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/pro-balans/tolko-sprosit/kak-rabotat-so-slozhnymi-emocionalnymi-sostoyaniyami 2025-07-28T09:43:13+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis/siponimod-video/patogenesys 2025-10-16T13:25:13+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis/siponimod-video/patogenesys-part-two 2025-10-16T13:26:21+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis/siponimod-video/criteria-for-treatment-success 2025-10-16T13:29:52+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis/siponimod-video/diagnostics 2025-10-16T13:31:50+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/webinars/podhody-k-obespecheniyu-terapiey 2025-07-28T09:46:15+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/chto-vazhno-znat-o-bezopasnosti-mirnk 2025-06-24T08:14:55+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/webinars/opyt-lekarstvennogo-obespecheniya-v-rostovskoy-oblasti 2025-07-28T09:42:15+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/ophtalmology/retinal-diseases/information/amd/vozrastnaya-makulyarnaya-degeneraciya 2025-06-27T13:50:21+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis/siponimod-video/clinical-case 2025-10-16T13:31:01+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/webinars/podhody-k-vedeniyu-pacientov-s-ostroy-rtph 2025-07-28T09:38:23+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/webinars/opyt-primeneniya-ruksolitiniba-pri-rtph 2025-07-28T09:37:02+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/webinars/voprosy-marshrutizacii-pacientov-s-rtph 2025-07-28T09:35:48+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/promedlenie-opasno-opyt-vedeniya-pacientov-s-nerentgenologicheskim-aksialnym-spondiloartritom-na-primere-kaliningradskoy-oblasti 2025-12-23T10:26:55+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/pro-balans/tolko-sprosit/kak-stat-horoshim-kommunikatorom 2025-07-31T09:53:25+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/taktika-vedeniya-pacientov-so-spondiloartritom-v-realnoy-klinicheskoy-praktike 2025-12-23T10:27:13+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/webinars/podhody-k-vedeniyu-pacientov-s-hronicheskoy-rtph 2025-07-28T09:33:48+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/webinars/ipmf4-lomaia 2025-07-28T09:32:01+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/webinars/ipmf4-passamonti 2025-07-28T09:31:04+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/webinars/pacient-s-mielofibrozom-1 2025-07-28T09:28:56+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/webinars/pacient-s-mielofibrozom-2 2025-07-28T09:28:14+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/webinars/podbor-dozy-ruksolitiniba 2025-07-28T11:21:25+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/webinars/target-therapy-clinical-case 2025-07-28T09:26:33+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/webinars/mielofibrosys 2025-07-25T13:10:03+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/webinars/true-polycythemia-modern-approach 2025-07-25T13:08:03+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/webinars/patients-destiny 2025-07-25T12:43:23+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/webinars/true-polycythemia 2025-07-28T09:23:46+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/webinars/epidemiology 2025-07-25T12:39:17+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/webinars/prakticheskie-voprosy 2025-07-25T12:37:35+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/kofe-s-ekspertom-combi-aplus 2025-11-21T13:04:29+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/webinars/shpargalka-gematologa-metodika-provedeniya-trepanobiopsii 2025-07-23T12:49:42+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/ophtalmology/retinal-diseases/information/amd/klinicheskaya-effektivnost-anti-vegf 2025-07-10T11:03:03+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/ophtalmology/retinal-diseases/information/amd/klinicheskoe-znachenie-zhidkosti-v-setchatke 2025-07-21T07:46:21+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/ophtalmology/retinal-diseases/information/diabeticheskaya-retinopatiya 2025-07-21T07:54:18+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/ranniy-aksialnyy-spondiloartrit-kak-mediko-socialnaya-problema 2025-12-23T10:26:59+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/skorost-vyzhivaemost-bezopasnost-kompleksnyy-podhod-k-vyboru-genno-inzhenernyh-biologicheskih-preparatov-dlya-terapii-pacientov-s-nerentgenologicheskim-aksialnym-spondiloartritom 2025-12-23T10:27:09+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/webinars/posledovatelnost-terapii-pri-braf-melanome-kozhi 2025-07-16T14:36:26+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/nerentgenologicheskiy-aksspa-v-poiskah-optimalnogo-algoritma-diagnostiki-i-vedeniya-pacientov 2025-12-23T10:26:44+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/vremya-ne-zhdet-opyt-novosibirskoy-oblasti-v-rannem-vyyavlenii-pacientov-s-aksspa 2025-12-23T10:27:21+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/taktika-vedeniya-pacientov-s-nr-aksspa-v-usloviyah-realnoy-klinicheskoy-praktiki-rossiyskoy-federacii 2025-07-25T10:27:57+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/terapevticheskie-oblasti/onkologiya/melanoma/vebinari-lektsii-dokladi/kofe-s-ekspertom-sravnenie 2025-07-15T13:29:28+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/karamova-arfenya-eduardovna---kak-uvidet-svoevremenno-aktualnye-podhody-k-vyyavleniyu-artrita-u-pacientov-s-psoriazom-glazami-dermatologa 2025-12-23T10:26:25+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/korotaeva-tatyana-viktorovna---osnovnye-tendencii-diagnostiki-i-terapii-porazheniya-pozvonochnika-pri-psa-v-rossii 2025-12-23T10:26:27+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/shesternya-pavel-anatolevich---realizaciya-programmy-skrininga-i-marshrutizacii-pacientov-s-psa-v-krasnoyarskom-krae 2025-12-23T10:27:05+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/kak-ocenit-aktivnost-eaa-u-detey 2025-12-23T10:26:16+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/kak-zapodozrit-eaa-u-detey 2025-12-23T10:26:20+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/kak-zapodozrit-porazhenie-pozvonochnika-pri-eaa-u-detey 2025-12-23T10:26:22+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/kak-vyyavit-entezity-u-detey 2025-07-25T10:05:56+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/webinars/vozvrat-k-targetnoy-terapii-v-pozdnih-liniyah-lecheniya 2025-07-16T14:37:55+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/diagnostika-entezit-associirovannogo-artrita-u-detey-valieva-si 2025-12-23T10:26:12+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/korotaeva-tv-osnovnye-tendencii-diagnostiki-i-terapii-porazheniya-pozvonochnika-pri-psa-v-rossii 2025-12-23T10:26:39+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/ophtalmology/retinal-diseases/information/dmo 2025-09-17T14:46:58+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/webinars/combi-ad 2025-11-21T13:04:48+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/mozhno-li-vyyavit-psa-vovremya-osnovnye-prediktory-progressirovaniya-porazheniya-sustavov-vasilenko-aa 2025-12-23T10:26:43+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/differencialnaya-diagnostika-aksilnogo-psa-glazami-rentgenologa-osnovnye-oshibki-i-resheniya-smirnov-av 2025-12-23T10:26:13+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/racionalnoe-primenenie-uzi-dlya-raneey-diagnostiki-artritov-i-entezitov-pri-psa-dyomina-ab 2025-12-23T10:26:58+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/koksit-kak-chast-mozaiki-spondiloartritov-mozhem-li-my-naznachat-ingibitory-il-17 2025-12-23T10:26:25+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/webinars/kak-dobitsya-mediany-ov-v-404-mesyaca 2025-11-21T13:04:49+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/webinars/patsienti-s-metastazami-melanomi-v-golovnoi-mozg-kak-lechit 2025-07-15T13:26:56+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/smozhem-li-my-nayti-universalnyy-put-v-lechenii-aksialnogo-spondiloartrita-osnovnye-principy-pri-vybore-strategii-terapii 2025-12-23T10:27:10+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/bystro-ili-nadolgo-kak-rasstavit-prioritety-pri-vybore-terapii-gibp-dlya-pacienta-s-aksialnym-spondiloartritom 2025-12-23T10:26:10+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/v-gostjah-u-revmatologa-sladko-zhit-ne-zapretish 2025-12-23T10:27:19+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/dela-serdechnye 2025-07-24T14:48:59+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/webinars/kak-uluchshit-vizhivaemost-patsientov-s-melanomoi-kozhi 2025-11-21T13:04:50+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/webinars/pervaya-liniya-terapii-braf-metastaticheskoi-melanomi-kozhi-chto-vibrat 2025-07-15T13:25:37+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/cases/klinicheskiy-sluchay-po-retreatment-pri-melanome-kozhi 2025-11-21T13:04:21+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/v-gostjah-u-revmatologa-preduprezhden-znachit-vooruzhen 2025-12-23T10:27:17+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/secret-key-to-diagnosis 2025-12-23T10:27:04+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/what-do-philosophers-think 2026-02-19T06:59:52+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/marshrutizaciya-pacientov-s-aksspa-v-rf-problemy-i-resheniya 2025-12-23T10:26:41+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/cases/klinicheskiy-sluchay-metastaticheskoy-melanomy-kozhi--s-blagopriyatnym-prognozom 2025-11-21T13:04:21+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/ophtalmology/retinal-diseases/information/retinopatiya-nedonoshennyh 2025-07-18T20:13:29+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/ophtalmology/retinal-diseases/information/khorioidalnaya-neovaskulyarizatsiya-obshchaya-informatsiya 2025-07-15T13:03:01+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/bylieve 2025-07-10T07:16:39+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/ophtalmology/retinal-diseases/information/hereditary-retinal-dystrophy/nds-s-mutaciyami-v-gene-rpe65 2025-07-15T13:07:27+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/optimizaciya-puti-pacienta-s-vospalitelnoy-boli-v-spine-v-realnoy-klinicheskoy-praktike-opyt-udmurtskoy-respubliki%23 2025-12-23T10:26:54+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/ophtalmology/retinal-diseases/information/hereditary-retinal-dystrophy/test-mobilnosti-pacienta-v-prostranstve-pri-raznyh-urovnyah-osveshchennosti-mlmt 2025-07-15T13:09:21+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/optimizaciya-puti-pacienta-s-vospalitelnoy-boli-v-spine-v-realnoy-klinicheskoy-praktike-opyt-kaliningradskoy-oblasti 2025-12-23T10:26:49+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/optimizaciya-puti-pacienta-s-vospalitelnoy-boli-v-spine-v-realnoy-klinicheskoy-praktike-opyt-tyumenskoy-oblasti 2025-07-24T14:48:17+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/novye-dokazatelstva-metabolicheskoy-disregulyacii-i-sistemnogo-vospaleniya-pri-psoriaticheskom-artrite-po-dannym-pet-kt-pacientov-s-psa 2025-12-23T10:27:46+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/rezultat-klinicheskogo-ispytaniya-fazy-iii-ultimate 2025-12-23T10:27:01+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/ophtalmology/retinal-diseases/information/hereditary-retinal-dystrophy/ocenka 2025-07-17T14:32:40+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/ankiloziruyushchiy-spondilit-i-aksialnyy-psoriaticheskiy-artrit-shodstva-i-razlichiya 2025-07-24T14:48:15+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/axial-psa 2025-12-23T10:26:09+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/treatment-algorithm 2025-12-23T10:27:23+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/significance-of-cardiovascular-comorbidity 2025-12-23T10:27:07+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/psa-patient-monitoring 2025-12-23T10:26:58+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/activity-score 2025-12-23T10:26:06+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/initial-examination 2025-12-23T10:26:17+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/focus-on-nail-damage 2025-12-23T10:26:14+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/osmotr-pacienta-s-aksspa 2025-12-23T10:26:53+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/ophtalmology/retinal-diseases/information/hereditary-retinal-dystrophy/rol-geneticheskogo-tipirovaniya 2025-07-17T14:35:23+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/sbor-anamneza-u-pacienta-s-aksspa 2025-07-24T14:34:10+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/psoriatic-and-rheumatoid-arthritis 2025-12-23T10:26:59+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/ankiloziruyushchiy-spondilit 2025-07-24T14:32:43+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/nerentgenologicheskiy-aksialnyy-spondiloartrit 2025-12-23T10:26:43+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/ophtalmology/retinal-diseases/information/hereditary-retinal-dystrophy/gennaya-terapiya 2025-07-31T12:21:21+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/kriterii-postanovki-diagnoza-aksspa 2025-12-23T10:26:40+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/povtornyy-vizit-i-monitoring-sostoyaniya-pacienta-s-aksspa 2025-12-23T10:26:53+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/ocenka-entezitov-u-pacienta-s-aksspa 2025-12-23T10:26:46+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/algoritmy-vedeniya-pacientov-s-aksspa 2025-12-23T10:26:07+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/ocenka-funkcionalnoy-aktivnosti-pacienta-s-aksspa 2025-07-24T14:28:36+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/ocenka-boli-u-pacienta-s-aksspa 2025-12-23T10:26:46+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/vedenie-pacientov-s-gnoynym-gidradenitom-vzaimodeystvie-dermatologov-i-hirurgov/effektivnost-sekukinumaba-v-issledovaniyah-sunshine-i-sunrise 2025-07-31T10:32:42+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/vedenie-pacientov-s-gnoynym-gidradenitom-vzaimodeystvie-dermatologov-i-hirurgov/taktika-vedeniya-pacienta-s-gnoynym-gidradenitom-i-svishchevymi-hodami 2025-07-31T10:34:24+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/vedenie-pacientov-s-gnoynym-gidradenitom-vzaimodeystvie-dermatologov-i-hirurgov/kriterii-dlya-svoevremennogo-naznacheniya-genno-inzhenernoy-biologicheskoy-terapii-u-pacientov-s-gg 2025-07-31T10:32:08+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/vedenie-pacientov-s-gnoynym-gidradenitom-vzaimodeystvie-dermatologov-i-hirurgov/vospalitelnaya-i-nevospalitelnaya-formy-gg-taktika-vedeniya 2025-07-31T10:35:27+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/vedenie-pacientov-s-gnoynym-gidradenitom-vzaimodeystvie-dermatologov-i-hirurgov/algoritm-lecheniya-obostreniy-gg 2025-07-23T12:28:45+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/vedenie-pacientov-s-gnoynym-gidradenitom-vzaimodeystvie-dermatologov-i-hirurgov/kak-ocenivat-klinicheskiy-otvet-u-pacientov-s-gg-ocenka-po-shkale-ihs4 2025-07-31T10:33:40+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/ophtalmology/retinal-diseases/reviews/harbor 2025-09-12T13:03:21+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/ophtalmology/retinal-diseases/reviews/anti-vegf-terapiya-pri-ocvs-i-ovvs 2025-09-12T13:02:08+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/ophtalmology/retinal-diseases/reviews/anti-vegf-pri-dmo 2025-07-10T14:20:25+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/ophtalmology/retinal-diseases/materials/esli-diagnostirovana-vmd 2025-06-26T15:18:03+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/ophtalmology/posobie-dlya-vrachey-oftalmologov-neinfekcionnoe-vgv 2025-06-26T15:31:42+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/ophtalmology/retinal-diseases/information/okklyuziya-ven-setchatki 2025-07-18T20:11:41+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/korotkie-video/diagnosticheskie-kriterii-gnoynogo-gidradenita 2025-12-23T09:07:44+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/psoriasis/video/rodvk-recomendations/laboratory-diagnostic-tests 2025-12-23T09:08:29+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/korotkie-video/gnoynyy-gidradenit-sistema-herliihs-4 2025-12-23T09:07:48+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/ophtalmology/retinal-diseases/reviews/protocol-s-i-pride 2025-09-12T13:04:08+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/korotkie-video/gnoynyy-gidradenit-okno-vozmozhnostey 2025-12-23T09:07:47+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/korotkie-video/gnoynyy-gidradenit-mezhdunarodnye-klinicheskie-rekomendacii-osnovnye-celi-lecheniya 2025-12-23T09:09:14+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/psoriasis/video/rodvk-recomendations/scales-for-rating-levels-of-evidence 2025-12-23T09:08:39+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/korotkie-video/gipb-pri-gnoynom-gidradenite-issledovaniya-sunrise-i-sunshine 2025-12-23T09:09:19+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/korotkie-video/klinicheskiy-sluchay-pacienta-s-gnoynym-gidradenitom 2025-12-23T09:07:49+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/korotkie-video/marshrutizaciya-pacientov-s-gnoynym-gidradenitom-v-sankt-peterburge 2025-12-23T09:07:50+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/psoriasis/video/rodvk-recomendations/treatment 2025-12-23T09:08:35+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/video/konservativno-vesti-nelzya-operirovat-gde-postavit-zapyatuyu-pri-obrashchenii-pacienta-s-gnoynym-gidradenitom 2025-12-23T09:08:08+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/psoriasis/video/rodvk-recomendations/metotrecsat 2025-12-23T09:08:31+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/video/zagadochnyy-gnoynyy-gidradenit 2025-12-23T09:08:15+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/psoriasis/video/rodvk-recomendations/retinoids-and-cyclosporine 2025-12-23T09:08:32+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/video/ocenochnye-shkaly-gidradenita-interaktiv-klinicheskiy-razbor-pacienta-so-srednetyazhelym-gg 2025-12-23T09:08:09+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/psoriasis/video/rodvk-recomendations/phototherapy 2025-12-23T09:08:43+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/video/hirurgicheskoe-lechenie-i-genno-inzhenernaya-biologicheskaya-terapiya-pri-gnoynom-gidradenite 2025-12-23T09:08:07+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/psoriasis/video/rodvk-recomendations/genetically-engineered-biological-products 2025-12-23T09:08:29+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/video/voprosy-etiologii-i-patogeneza-gnoynogo-gidradenita-klinicheskie-fenotipy 2025-12-23T09:08:13+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/psoriasis/video/rodvk-recomendations/secukinumab 2025-12-23T09:08:34+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/video/vybor-strategii-vedeniya-agressivnyy-podhod-v-terapii-klinicheskiy-razbor-pacienta-s-tyazhelym-gg 2025-12-23T09:08:14+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/psoriasis/video/potencialnye-vozmozhnosti-obespecheniya-pacientov-genno-inzhenernoy-biologicheskoy-terapiey-segodnya 2025-12-23T09:08:26+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/video/hidradenitis 2025-12-23T09:08:05+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/video/rating-scales-and-treatment-algorithms 2025-12-23T09:09:39+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/psoriasis/video/ranee-vmeshatelstvo-v-terapii-psorisa-razgovor-s-ekspertom 2025-07-23T12:15:28+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/video/chronic-hidradeniti-suppurativa 2025-12-23T09:08:04+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/video/immunological-mechanisms 2025-12-23T09:08:07+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/video/pathogenesis-of-hidradenitis 2026-02-19T07:43:42+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/video/hidradeniti-suppurativa 2025-12-23T09:09:42+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/patient-stories/labyrinth-of-the-patients-target-audience 2025-12-23T09:07:54+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/patient-stories/out-of-shadow 2025-12-23T09:09:53+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/psoriasis/video/klinicheskiy-sluchayrannego-naznacheniya-gibt-pri-tyazheloy-forme-psoriaza 2025-07-23T12:19:18+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/psoriasis/video/vybor-genno-inzhenernogo-preparata-dlya-lecheniya-psoriaza 2025-12-23T09:08:37+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/psoriasis/video/koncepciya-step-in 2025-07-23T13:06:00+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/migren/vebinary-lekcii-doklady/veynovskie-chteniya-monoklonalnye-antitela-v-borbe-s-migrenyu-personalizirovannyy-podhod-k-terapevticheskomu-uspehu 2025-07-23T12:20:27+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/psoriasis/video/specifika-genno-inzhenernoy-biologicheskoy-terapii-pri-psoriaze-u-detey 2025-12-23T09:08:36+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/education/module-1 2025-12-23T09:07:41+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/migren/vebinary-lekcii-doklady/profilaktika-migreni-priem-pacienta-s-golovnoy-bolyu 2025-07-24T13:35:47+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/migren/vebinary-lekcii-doklady/targetnaya-terapiya-migreni 2026-02-27T12:59:10+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/migren/vebinary-lekcii-doklady/effektivnost-i-bezopasnost-mat-k-cgrp-v-klinicheskoy-praktike 2026-02-27T12:58:26+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/education/module-2 2025-12-23T09:09:48+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/education/module-3 2025-12-23T09:10:22+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/education/module-4 2025-12-23T09:07:42+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/education/module-5 2025-07-21T14:21:00+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/autovospalitelnie-zabolevaniya/clinrec/juvenile-arthritis 2025-12-23T10:24:59+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/%D1%82%D0%B5%D1%80%D0%B0%D0%BF%D0%B5%D0%B2%D1%82%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5-%D0%BE%D0%B1%D0%BB%D0%B0%D1%81%D1%82%D0%B8/%D0%B3%D0%B5%D0%BC%D0%B0%D1%82%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D1%8F/%D1%82%D0%B5%D1%80%D0%B0%D0%BF%D0%B8%D1%8F-%D0%BE%D0%BC%D0%BB-%D0%B8%D0%BD%D0%B3%D0%B8%D0%B1%D0%B8%D1%82%D0%BE%D1%80%D0%B0%D0%BC%D0%B8-%D0%BF%D1%80%D0%BE%D1%82%D0%B5%D0%B8%D0%BD%D0%BA%D0%B8%D0%BD%D0%B0%D0%B7 2025-07-24T08:06:12+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/lungcancer/webinars/osnovnye-aspekty-mutacii-v-gene-met-pri-nmrl-prichiny-posledstviya-narusheniy 2025-06-30T13:06:15+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/lungcancer/webinars/pochemu-immunnaya-terapiya-maloeffektivna-pri-narusheniyah-v-gene-met-pri-nmrl 2025-06-30T13:08:07+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/lungcancer/webinars/problemy-lecheniya-raka-legkogo-s-aktiviruyushchimi-drayvernymi-mutaciyami 2025-07-22T10:37:57+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/lungcancer/webinars/rol-metoda-ngs-v-poiske-narusheniy-v-gene-met-pri-nmrl 2025-06-30T13:11:02+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/aplasticheskaya-anemiya 2025-06-27T16:44:49+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/%D1%82%D0%B5%D1%80%D0%B0%D0%BF%D0%B5%D0%B2%D1%82%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5-%D0%BE%D0%B1%D0%BB%D0%B0%D1%81%D1%82%D0%B8/%D0%B3%D0%B5%D0%BC%D0%B0%D1%82%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D1%8F/%D0%BE%D1%81%D1%82%D1%80%D1%8B%D0%B9-%D0%BC%D0%B8%D0%B5%D0%BB%D0%BE%D0%B8%D0%B4%D0%BD%D1%8B%D0%B9-%D0%BB%D0%B5%D0%B9%D0%BA%D0%BE%D0%B7-0 2025-07-24T08:05:13+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/covid-i-itp 2025-07-24T09:23:14+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/dieticheskie-rekomendacii 2025-07-24T09:24:45+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/aplasticheskaya-anemiya/klassifikaciya 2025-07-24T08:11:50+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/pro-balans/serial-govoryat-na-yuridicheskom/skoraya-socialnaya-pomoshch 2025-07-25T12:34:35+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/dannye-realnoy-praktiki-o-klinicheskih-ishodah-itp 2025-07-23T10:01:57+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/pulmonologiya/video/biologicheskaya-terapiya-dlya-patsientov-s-tyazheloy-ba-i-sochetannym-profilem-avdeev-bobrikova 2026-03-18T14:38:29+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/eltrombopag-dozirovanie-i-titraciya-dlya-pacientov-s-itp 2025-07-24T09:29:03+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/eltrombopag-v-lechenii-itp 2025-07-24T09:45:27+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/pulmonologiya/video/kak-pomoch-patsientu-s-ba-instrumenty-i-layfkhaki-kak-povysit-priverzhennost-terapii-avdeev-aysanov 2026-03-18T14:38:30+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/pulmonologiya/video/stupen-4-i-stupen-5-tonkaya-gran-u-patsientov-s-tyazheloy-ba-razbiraemsya-v-podkhodakh-k-terapii-avdeev-petukhova 2026-03-18T14:38:31+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/pulmonologiya/video/how-to-use-capsules-with-powder-for-inhalation 2026-03-11T13:34:05+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/eltrombopag-v-lechenii-itp-u-detey 2025-07-24T10:19:30+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/sma/information/princip-deystviya-genozamestitelnoy-terapii 2025-07-24T13:29:57+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/mesto-eltrombopaga-v-terapii-itp 2025-07-23T07:14:28+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/eltrombopag-v-pervoy-linii-terapii-taa 2025-07-24T10:26:46+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/mesto-eltrombopaga-v-terapii-aa 2025-07-23T07:11:14+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/mehanizm-deystviya-eltrombopaga 2025-07-17T12:14:21+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/autovospalitelnie-zabolevaniya/interaktivnie-diagnosticheskie-kriterii/gout 2025-12-23T10:25:04+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/eltrombopag-v-sravnenii-s-romiplostimom-v-lechenii-detey 2025-07-17T12:55:22+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/eltrombopag-v-terapii-refrakternoy-taa 2025-07-02T06:45:07+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/axial-spondyloarthritis/fakty-ob-aksspa-aksialnom-spondiloartrite 2025-12-23T10:25:11+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/idiopaticheskaya-trombocitopenicheskaya-purpura 2025-07-02T11:44:53+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/mezhdunarodnaya-sistema-ocenki-tyazhesti-gnoynogo-gidradenita-shkala-ihs-4 2025-12-23T09:07:51+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis/clinical-cases/case-1 2025-09-30T08:34:38+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis/clinical-cases/case-2 2025-09-30T09:22:43+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis/clinical-cases/case-3 2025-09-30T09:23:51+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis/clinical-cases/case-4 2025-09-30T09:24:54+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis/video/ofatumumab 2025-09-30T08:29:48+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis/video/siponimod-mehanizm-dejstviya 2025-10-16T13:19:37+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/kriterii-diagnostiki-aplasticheskoy-anemii 2025-07-02T12:24:30+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/congresses/obedinennyy-vii-kongresss-gematologov-i-iv-kongress-transfuziologov-rossii/asciminib---rezultaty-primeneniya-v-klinicheskoy-praktike-u-bolnyh-hronicheskim-mieloleykozom 2025-07-03T09:26:34+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/congresses/obedinennyy-vii-kongresss-gematologov-i-iv-kongress-transfuziologov-rossii/asciminib---vzglyad-v-budushchee 2025-07-03T09:29:11+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/congresses/obedinennyy-vii-kongresss-gematologov-i-iv-kongress-transfuziologov-rossii/mozhet-li-asciminib-uluchshit-rezultat-allo-gksk-u-pacientov-s-hronicheskim-mieloleykozom 2025-07-03T09:35:00+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/congresses/obedinennyy-vii-kongresss-gematologov-i-iv-kongress-transfuziologov-rossii/sovremennye-podhody-k-terapii-mielofibroza-i-istinnoy-policitemii-v-rossiyskoy-federacii 2025-07-03T09:36:30+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/itp-u-vzroslyh 2025-07-02T14:47:43+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/congresses/obedinennyy-vii-kongresss-gematologov-i-iv-kongress-transfuziologov-rossii/magiya-v-mieloproliferativnyh-novoobrazovaniyah-rezultaty-issledovaniya-majic-mesto-ruksolitiniba-v-terapii-pacientov-s-ip 2025-07-03T09:38:25+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/congresses/obedinennyy-vii-kongresss-gematologov-i-iv-kongress-transfuziologov-rossii/10-let-vmeste-s-ruksolitinibom-zasluzhennyy-uspeh 2025-07-03T12:09:44+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/congresses/obedinennyy-vii-kongresss-gematologov-i-iv-kongress-transfuziologov-rossii/master-klass-po-trepanobiopsii 2025-07-03T09:43:39+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/congresses/roc-2023/pik3ca 2025-07-03T09:47:28+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/congresses/roc-2023/rok-2023-satellitnyy-simpozium-kafedra-onkologii-segodnya-razbiraem-melanomu 2025-07-03T09:46:10+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/congresses/asco-2023/asco-news-pik3ca 2025-07-18T20:04:53+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/congresses/asco-2023/asco-news-right-choice 2025-07-18T08:05:30+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/itp-u-detey 2025-07-23T12:22:30+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/cases/klinicheskiy-sluchay-adyuvantnoy-terapii-u-pacientki-s-mutaciey-braf-v600k 2025-11-21T13:04:19+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/obzor-obnovlennogo-konsensusnogo-otcheta-po-lecheniyu-itp 2025-07-25T12:12:03+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/podhody-k-terapii-itp 2025-07-23T08:10:23+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/congresses/asco-2023/asco-news-treatment-of-patients-with-resectable-melanoma 2025-07-16T08:24:21+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/rezhim-dozirovaniya-eltrombopaga 2025-07-23T08:23:10+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/congresses/asco-2023/asco-news-treatment-of-patients-with-metastatic-melanoma 2025-07-16T08:23:44+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/spondiloartrity-i-serdechno-sosudistye-riski-vedem-sami-ili-napravlyaem-kardiologu-napravlem-k-kardiologu 2025-07-23T13:44:36+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/spondiloartrity-i-serdechno-sosudistye-riski-vedem-sami-ili-napravlyaem-kardiologu-sami 2025-07-23T13:37:32+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/systemic-mastocytosis/information 2025-07-23T09:05:22+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/congresses/real-clinical-practice 2025-07-29T10:28:37+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/reviews/issledovanie-rationale-rezultaty-adyuvantnoy-targetnoy-terapii-pri-melanome-kozhi-v-rossii 2026-02-18T13:38:52+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/information/kak-opredelyayut-stadiyu-melanomy-kozhi-klassifikaciya-tnm 2025-11-21T13:04:24+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/systemic-mastocytosis/reviews 2025-07-23T09:07:21+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/talassemiya 2025-07-23T09:15:40+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/congresses/real-clinical-practice/zvartau 2025-07-04T20:19:35+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/congresses/real-clinical-practice/ionova 2025-07-04T20:37:56+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/congresses/real-clinical-practice/artamonova 2025-07-04T20:52:39+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/vzaimodeystvie-revmatologa-i-dermatologa-prikaz-ili-dobraya-volya-prikaz 2025-07-23T13:32:49+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/vliyanie-sekukinumaba-na-progressirovanie-entezofitov-i-eroziy-u-pacientov-s-psoriaticheskim-artritom-rezultaty-godovogo-issledovaniya-s-ispolzovaniem-specialnoy-kompyuternoy-tomografii-vysokogo-razresheniya 2025-07-23T13:50:43+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/rol-vospaleniya-i-strukturnyh-izmeneniy-na-mrt-kps-v-diagnostike-aksspa 2025-07-23T12:18:07+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/rol-mrt-izmeneniy-pri-aksspa-v-prognozirovanii-strukturnogo-progressirovaniya-i-vozmozhnosti-ego-predotvrashcheniya 2025-07-23T12:16:45+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/registry-pacientov-i-dolgosrochnye-nablyudatelnye-issledovaniya 2025-07-23T13:05:13+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/vliyanie-sekukinumaba-na-progressirovanie 2025-07-24T06:53:01+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/telesto 2025-07-23T09:16:42+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis/articles/clinical-recommendations 2025-07-21T12:32:08+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/sravnenie-pokazateley-dolgosrochnoy-celesoobraznosti-primeneniya-iil-17-i-ifno-- 2025-07-23T13:26:43+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/kak-uvidet-nevidimoe-rentgenologicheskaya-progressiya-my-rano-pro-neyo-zabyli 2025-07-24T07:09:13+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/trudno-poddayushiisa-patient-s-psa-part2 2025-07-23T12:40:22+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/vzaimodeystvie-revmatologa-i-dermatologa-prikaz-ili-dobraya-volya-dobraya-volya 2025-07-23T13:34:03+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/gorizonty-primeneniya-il17-v-praktike-revmatologa-spondiloartritom-edinym-da 2025-07-23T13:30:50+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/nefrologiya/diagnostika/kogda-sleduet-delat-biopsiyu-u-pacientov-perenesshih-transplantaciyu-pochki-vsledstvie-glomerulopatii 2026-03-31T06:42:20+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/therapeutical-areas/rheumatology/autovospalitelnie-zabolevaniya/clinrec/t2t-treat-to-target-rekomendacii-po-lecheniyu-gigantokletochnogo-arteriita-gka-i-revmaticheskoy-polimialgii-rpm 2025-12-23T10:26:05+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/axial-spondyloarthritis/differencialnaya-diagnostika 2025-12-23T10:25:10+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/pro-balans/lets-get-personal 2025-07-24T19:59:56+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/autovospalitelnie-zabolevaniya/klinicheskie-sluchai/semejnaya-sredizemnomorskaya-lihoradka 2025-07-09T10:50:15+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/autovospalitelnie-zabolevaniya/klinicheskie-sluchai/kriopirin-associirovannyj-sindrom 2025-12-23T10:25:05+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis/materials/neda-3-otstutstvie-priznakov-aktivnosti-zabolevaniya 2025-07-25T11:54:48+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis-main/dr-hauser/asclepios-vtorichnye-konechnye-tochki-izmenenie-obema-golovnogo-mozga-neyrofilamenty 2025-09-24T12:17:18+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/ophtalmology/retinal-diseases/materials/lechenie-nvmd 2025-07-10T12:25:20+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/migren/vebinary-lekcii-doklady/migren-360-intensiv-po-samoy-rasprostranennoy-golovnoy-boli-novye-podhody-k-lecheniyu-i-profilaktike 2025-07-23T12:32:38+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/migren/vebinary-lekcii-doklady/avtoinzhektor-erenumab 2025-11-25T07:35:45+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/prediktory-effektivnosti-i-prodolzheniya-terapii-gibp-u-pacientov-s-aksspa 2025-07-23T11:50:58+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/psoriasis/video/indications-for-gebd-therapy 2025-12-23T09:08:25+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/terapiya-hr-her2--mrmzh-v-rossii-v-2023-godu-veter-peremen 2025-07-25T10:42:06+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/nefrologiya/aktualnye-voprosy/62-y-kongress-evropeyskoy-nefrologicheskoy-associacii-era-2025-vyhod-za-predely-nefrologii 2026-03-17T09:52:44+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis/articles/vysokoeffektivnye-pitrs-est-li-raznica 2025-09-22T14:14:28+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/psoriasis/video/rodvk-recomendations/diagnostics 2025-12-23T09:08:28+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/axial-spondyloarthritis/uderzhanie-na-terapii-sekukinumabom-u-pacientov-s-psoriaticheskim-artritom-retrospektivnoe-kogortnoe-issledovanie-s-sopostavleniem-s-adalimumabom-na-osnove-bazy-dannyh-flyway 2025-12-23T10:25:30+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/endokrinologiya/saharnyy-diabet/vebinary-lekcii-doklady/mezhdisciplinarnyy-podhod--v-vedenii-pacienta-s-sad-2-go-tipa-vzglyad-endokrinologa-i-kardiologa 2026-03-11T13:47:38+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/nefrologiya/aktualnye-voprosy/kriterii-otsenki-katchestva-med-pomoshi-pri-hbp 2026-03-17T09:52:40+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis/siponimod-video/kak-zamedlit-prodolzhayuscheesya-progressirovanie-invalidizacii-u-pacientov-s-vprs-s-obostreniyami 2025-08-29T13:09:31+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis/siponimod-video/obzor-mezhdunarodnyh-dannyh-primenenia-siponimoda 2025-09-03T15:00:24+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis/opyt-primenenia-preparata-siponimod 2025-09-04T13:22:35+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis/klinicheski-sluchai-vprs 2025-09-04T13:27:18+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/reviews/risk-pireksii-pri-lechenii-dabrafenibom-i-trametinibom-snizhaetsya-s-vozrastom 2025-11-21T13:04:43+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis/articles/obzor-perehoda-s-okrelizumaba-na-ofatumumab-pacientov-s-rasseyannym-sklerozom 2025-09-23T11:09:10+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis/articles/primenenie-siponimoda-v-realnoy-klinicheskoy-praktike-v-rossii 2025-09-24T12:31:31+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/terapiya-aksialnogo-psoriaticheskogo-artrita-istoriya-odnogo-issledovaniya 2025-09-24T12:50:49+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/video/sovremennye-podkhody-k-lecheniyu-gnoynogo-gidradenita-zapis-vebinara 2026-02-19T07:42:10+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/vybor-terapii-pri-as-soputstvuyushchiy-faktory-riska-serdechno-sosudistyh-oslozhneniy 2025-10-14T09:10:03+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/natalee-rki-iii-fazy-dlya-izucheniya-effektivnosti-i-bezopasnosti-kombinacii-ribocikliba-s-ingibitorom-aromatazy-dlya-adyuvantnoy-terapii-hr-her2--rmzh-iiiii-stadii 2025-11-19T13:22:40+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis/articles/novosti-41-go-mezhdunarodnogo-kongressa-ectrims-2025 2025-11-12T10:58:08+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis/articles/novosti-6-go-kongressa-rokirs-2025 2025-11-12T11:48:41+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/psoriasis/video/prakticheskie-rekomendaczii-pered-naznacheniem-gibp-posleduyushhij-monitoring-u-paczientov-s-pso-i-psa 2025-12-05T07:24:59+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/psoriasis/video/svoevremennoe-v-tom-chisle-rannee-naznachenie-gibp-u-paczientov-s-pso-i-psa 2025-12-05T12:00:46+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/psoriasis/video/dokazatelnyj-podkhod-k-vyboru-gibp-u-paczientov-s-pso-i-riskami-psa-v-usloviyakh-ogranichennoj-instrumentalnoj-diagnostiki 2025-12-05T12:00:29+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/psoriasis/video/psoriaticheskaya-onikhodistrofiya-kak-rannee-proyavlenie-psoriaticheskogo-artrita-psa 2025-12-05T12:01:16+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/psoriasis/video/chto-mozhno-i-chego-nelzya-pri-effekte-uskolzaniya-v-kontekste-genno-inzhenernykh-biologicheskikh-preparatov 2025-12-05T12:01:00+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/psoriasis/video/aktualnye-aspekty-primeneniya-gibp-tip-antitela-immunogennost-pervichnye-i-vtorichnye-neotvetchiki-pereklyuchenie-na-drugoj-gibp 2025-12-05T12:01:30+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/psoriasis/video/kak-vliyaet-gibp-na-fertilnost-primenenie-pri-beremennosti-v-period-laktaczii 2025-12-05T12:01:46+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/psoriasis/video/pokazaniya-i-sroki-naznacheniya-gibp-u-paczientov-s-psoriazom-esli-bazisnaya-terapiya-ne-dala-dolzhnogo-effekta 2025-12-05T12:02:24+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/psoriasis/video/chto-rekomenduetsya-ispolzovat-dlya-skrininga-psoriaticheskogo-artrita-psa-na-ambulatornom-etape 2025-12-05T12:02:00+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/psoriasis/video/kak-na-rannem-etape-u-paczienta-s-psoriazom-pso-vyyavit-riski-razvitiya-psoriaticheskogo-artrita-psa 2025-12-05T12:02:23+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/psoriasis/video/kak-obyasnit-paczientu-chtoby-on-ne-boyalsya-naznacheniya-gibp 2026-02-10T10:13:30+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/hronicheskiy-mieloleykoz/kriterii-ocenki-kachestva-medicinskoy-pomoshchi-dlya-hml 2025-12-26T12:18:03+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/video/vebinar-programma-gosudarstvennyh-garantiy 2026-02-04T13:49:59+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/webinars/obnovlennye-dannye-po-effektivnosti-i-bezopasnosti-primeneniya-icdk-46-u-pacientov-starshey-vozrastnoy-gruppy 2026-02-05T12:22:00+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/dementia/pacient-s-demenciey-kak-povysit-priverzhennost-terapii 2026-02-27T06:18:09+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/dementia/sovremennye-metody-diagnostiki-i-lecheniya-demencii 2026-02-27T06:02:56+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/dementia/vedenie-pacienta-s-demenciey-s-telcami-levi-effektivnoe-vzaimodeystvie-nevrologa-i-psihiatra 2026-02-27T06:04:31+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/dementia/dolgosrochnoe-vedenie-pacientov-s-boleznyu-alcgeymera-razbor-klinicheskih-sluchaev 2026-02-27T06:04:15+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/dementia/geterogennost-bolezni-alcgeymera-chto-eto-oznachaet-v-realnoy-klinicheskoy-praktike 2026-02-27T06:01:39+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/dementia/rasprostranennost-bolezni-alcgejmera-v-mire 2026-02-27T05:59:25+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/dementia/kak-pravilno-polzovatsya-plastyrem 2026-02-26T14:33:49+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/novosti-sabcs-2025-alpelisib-v-sochetanii-s-fulvestrantom-posle-ingibitora-cdk46-pri-hr-her2-rrmzh-s-mutaciey-pik3ca-rezultaty-issledovaniya-epik-b5 2026-02-26T07:17:07+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews/novosti-sabcs-2025-vyzhivaemost-bez-otdalennyh-metastazov-vbom-v-klyuchevyh-podgruppah-pacientov-s-hr-her2-rannim-rmzh-v-issledovanii-natalee 2026-03-03T07:51:04+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/opasnaya-svyaz-serdce-i-aksialnyy-spondiloartrit---kak-vystroit-strategiyu-upravleniya-riskami 2026-03-26T07:11:14+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/kurs-na-ustoychivuyu-remissiyu-v-lechenii-psoriaticheskogo-artrita 2026-03-26T07:11:09+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/klinicheskiy-sluchay-3-klinicheskiy-razbor-vedeniya-pacienta-s-akspsa 2026-03-31T12:17:23+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/klinicheskiy-sluchay-2-razbor-vedeniya-pacienta-s-psa 2026-03-31T12:17:27+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars/klinicheskiy-sluchay-1-pacient-s-psoriazom-i-prediktorami-razvitiya-psoriaticheskogo-artrita 2026-03-31T12:17:29+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/korotkie-video/gnoynyy-gidradenit-ekspertnoe-video-obrazovatelnyy-brif-po-gnoynomu-gidradenitu 2026-03-31T12:26:26+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/psoriasis/video/zenkevich-ev-klinicheskiy-sluchay-po-zabolevaniyu-deverzhi-chast-1 2026-03-31T13:28:49+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/psoriasis/video/zenkevich-ev-klinicheskiy-sluchay-po-zabolevaniyu-deverzhi-chast-2 2026-03-31T13:28:30+00:00 hourly 0.5 https://www.pro.novartis.com/ru-ru/node/1 2026-01-27T08:10:35+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/node/336 2025-08-26T11:16:43+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/node/341 2024-10-01T06:51:02+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/node/386 2024-11-18T08:17:18+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/node/471 2025-04-02T08:47:47+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas 2025-07-30T10:03:03+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/nozologiya-obschaya-informaciya 2025-05-13T09:35:25+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/nefrologiya 2026-03-23T12:02:47+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology 2026-02-24T07:49:55+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma 2025-12-26T08:07:24+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/atherosclerosis/clinical-case 2025-06-30T12:23:27+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/lipoprotein 2025-06-30T14:19:09+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology-intro 2025-07-25T13:38:37+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/Inclisiran-FAQ 2025-07-23T12:39:24+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/ehokg 2025-07-09T07:45:21+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/lipoprotein/biblioteka-video 2025-06-18T15:07:21+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/llo 2025-06-18T07:13:31+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/lipoprotein/klinicheskie-issledovaniya-i-obzory-landing 2025-06-30T13:02:15+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/hsn 2026-02-25T09:40:39+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/polimorbidnaya-akademiya-kompleksnyy-podhod-k-kompleksnoy-probleme 2025-06-30T13:11:42+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/atherosclerosis 2025-07-04T08:59:52+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/atherosclerosis/information 2025-06-30T15:01:11+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology 2025-12-29T12:01:39+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/cardiology/atherosclerosis/reviews 2025-06-19T15:43:59+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/polycythemia-vera/information 2025-07-16T06:46:21+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/essential-thrombocythemia 2025-06-20T15:18:29+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/reviews 2026-02-26T07:27:59+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/essential-thrombocythemia/information 2025-06-23T13:11:39+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/information 2025-06-23T13:34:52+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/reviews 2025-07-02T09:23:40+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/hronicheskiy-mieloleykoz 2025-12-26T15:17:48+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/reviews 2026-02-18T13:30:22+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer 2026-03-03T16:57:12+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/sma/materials 2025-07-14T12:44:42+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/sma/information/skrining-novorozhdennyh 2025-07-14T12:42:08+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/sma/information 2025-07-14T12:40:12+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/sma 2025-08-01T09:32:59+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/lungcancer/webinars 2025-07-01T10:23:59+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/lungcancer/reviews 2025-07-03T16:05:47+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/lungcancer/information 2025-06-24T17:33:12+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/lungcancer/cases 2025-06-24T17:37:54+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/lungcancer 2025-06-27T11:29:37+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/information 2025-11-21T13:04:23+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology 2025-12-26T07:29:04+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/terapevticheskie-oblasti/onkologiya/melanoma/govorim-o-melanome-za-chashkoi-kofe 2025-07-01T09:24:10+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/cases 2025-11-21T13:04:17+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/ophtalmology/retinal-diseases/information/amd 2025-07-10T08:39:49+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/ophtalmology/retinal-diseases/information 2025-07-10T08:33:41+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/ophtalmology/retinal-diseases 2025-07-30T12:36:22+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/ophtalmology 2025-07-25T13:41:55+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/ophtalmology/retinal-diseases/materials 2025-07-10T12:06:36+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/ophtalmology/retinal-diseases/clinrec 2025-07-10T11:46:14+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/ophtalmology/retinal-diseases/reviews 2025-07-10T11:56:04+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/psoriasis/informaciya-o-zabolevaniii 2025-08-20T08:50:28+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/psoriasis/materials 2025-12-23T09:08:23+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/nefrologiya/aktualnye-voprosy 2026-03-17T10:05:55+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/nefrologiya/biblioteka-video 2026-01-29T12:00:04+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/axial-spondyloarthritis 2025-12-23T10:25:07+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology 2025-12-23T10:23:16+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/autovospalitelnie-zabolevaniya/information 2025-12-23T10:24:59+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/psoriasis 2025-12-23T09:08:16+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology 2025-12-23T10:33:05+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/psoriasis/video 2026-03-31T13:35:38+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/webinars 2026-03-31T12:15:19+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/congresses 2025-07-23T14:20:58+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/congresses/obedinennyy-vii-kongresss-gematologov-i-iv-kongress-transfuziologov-rossii 2025-07-02T11:48:06+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/pro-balans 2025-07-04T07:59:15+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/pro-balans/stati-o-mentalnom-zdorove 2025-07-03T11:24:21+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/pro-balans/pod-belym-halatom 2025-07-03T10:36:02+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/pro-balans/tolko-sprosit 2025-07-03T11:04:32+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/pro-balans/serial-govoryat-na-yuridicheskom 2025-08-11T12:43:02+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/reviews 2025-12-23T09:07:56+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/vedenie-pacientov-s-gnoynym-gidradenitom-vzaimodeystvie-dermatologov-i-hirurgov 2025-12-23T09:08:02+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/korotkie-video 2026-03-31T12:30:34+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/education 2025-12-23T09:07:40+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/video 2026-02-04T13:56:16+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/patient-stories 2025-12-23T09:07:54+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty/vspomogatelnye-materialy 2025-12-23T09:08:16+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/materials 2025-07-03T15:17:16+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/information 2025-12-26T09:17:25+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/migren/vspomogatelnye-materialy 2025-07-03T16:21:01+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/migren/vebinary-lekcii-doklady 2025-07-14T14:53:48+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/migren 2025-12-08T13:02:55+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis/materials 2025-09-29T07:34:36+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/congresses/asco-2023 2025-07-21T07:28:18+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/congresses/roc-2023 2025-07-04T11:24:50+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/gidradenty 2025-12-23T09:07:39+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/endokrinologiya/saharnyy-diabet/klinicheskie-rekomendacii 2025-07-21T15:39:26+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/endokrinologiya/saharnyy-diabet/reviews 2025-07-21T15:40:59+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/endokrinologiya/saharnyy-diabet 2025-07-04T14:51:33+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/endokrinologiya/saharnyy-diabet/vebinary-lekcii-doklady 2025-08-06T08:22:54+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/pulmonologiya 2026-03-18T14:38:34+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/endokrinologiya 2025-07-21T12:34:33+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/detskiy-psoriaz/poleznye-materialy 2025-07-08T09:27:44+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/detskiy-psoriaz/video 2025-07-22T13:05:49+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/ophtalmology/retinal-diseases/information/hereditary-retinal-dystrophy-2 2025-07-10T11:50:47+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/yuvenilnyy-idiopaticheskiy-artrit/poleznye-materialy 2025-07-08T07:56:47+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/yuvenilnyy-idiopaticheskiy-artrit/videomaterialy 2025-07-08T08:22:11+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/yuvenilnyy-idiopaticheskiy-artrit/videomaterialy/pravila-vedeniya-pacientov-s-eaa 2025-07-08T08:33:40+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/yuvenilnyy-idiopaticheskiy-artrit/videomaterialy/pravila-vedeniya-pacientov-s-yupsa 2025-07-08T08:48:30+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/yuvenilnyy-idiopaticheskiy-artrit/videomaterialy/sprosi-u-revmatologa 2025-07-08T08:53:56+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/yuvenilnyy-idiopaticheskiy-artrit/videomaterialy/metody-instrumentalnoy-diagnostiki 2025-07-25T13:53:44+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/detskiy-psoriaz/video/pravila-vedeniya-malenkogo-pacienta-s--psoriazom 2025-07-17T14:07:32+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/detskiy-psoriaz/video/sovety-psihologa-kak-obshchatsya-s-roditelyami-i-malenkimi-pacientami 2025-07-17T14:05:43+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/detskiy-psoriaz/video/sprosi-u-dermatologa 2025-07-17T14:05:05+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis/siponimod-video 2025-09-29T11:16:42+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis-main/dr-hauser 2025-07-21T13:03:41+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis/video 2025-09-26T11:16:15+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis/clinical-cases 2025-09-29T09:17:19+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/multiple-sclerosis/articles 2025-11-12T10:54:29+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/autovospalitelnie-zabolevaniya 2025-12-23T10:24:58+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/autovospalitelnie-zabolevaniya/interaktivnie-diagnosticheskie-kriterii 2025-12-23T10:25:04+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/autovospalitelnie-zabolevaniya/interaktivnye-klinicheskie-sluchai 2025-07-16T11:47:12+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/autovospalitelnie-zabolevaniya/clinrec 2025-12-23T10:24:58+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/feedback 2026-03-12T14:59:56+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/products 2026-02-11T10:51:43+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology 2026-02-26T14:28:43+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/privacy-policy 2025-07-22T13:33:50+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/myeloproliferative-diseases/webinars 2025-07-28T14:56:53+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/video/video-1 2025-09-03T09:38:08+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/video/video-2 2025-09-03T09:38:09+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/video/video-3 2025-09-03T09:38:11+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/video/video-4 2025-09-03T09:38:12+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/video/video-5 2025-09-03T09:38:14+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/video/video-6 2025-09-03T09:38:15+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/video 2025-09-29T09:22:15+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/testavaya-stranics-tabi 2025-11-26T08:04:56+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/headliner 2025-10-21T15:08:59+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/iptakopan 2025-10-06T12:12:57+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/pnh 2025-10-06T12:12:54+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/oncode 2025-10-06T12:12:52+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/adjuvant-rmj 2025-10-17T13:43:26+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/braf 2025-10-17T09:05:52+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/headliner/dekretnyy-otpusk-bliznecy-migren-razbor-slozhnogo-klinicheskogo-sluchaya 2025-10-21T15:08:25+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/headliner/migren-o-soputstvuyushchih-emocionalnyh-slozhnostyah 2025-10-21T15:08:35+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/headliner/o-hronicheskoy-migreni-u-komorbidnogo-pacienta 2025-10-21T15:08:40+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/headliner/migren-v-treh-pokoleniyah 2025-10-21T15:08:41+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/headliner/abdominalnaya-migren-redkiy-diagnoz-kotoryy-izmenil-zhizn-pacientki 2025-10-21T15:08:43+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/headliner/slozhnyy-pacient-s-migrenyu-na-eranumabe 2025-10-21T15:07:49+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/headliner/podkast-s-ekspertami 2025-10-21T15:08:34+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/headliner/o-pristupah-migreni--v-neskolko-sutok 2025-10-21T15:08:30+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/headliner/mnogoletniy-sheynyy-osteohondroz-o-vazhnosti-pravilnogo-diagnoza 2025-10-21T15:08:27+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/dermatology/detskiy-psoriaz 2025-10-16T10:52:55+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/rheumatology/yuvenilnyy-idiopaticheskiy-artrit 2025-10-16T10:57:08+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/stopfever 2025-10-16T11:14:53+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/stopfever/overview-of-diseases/traps 2025-10-16T11:18:05+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/stopfever/overview-of-diseases/hids 2025-10-16T11:18:06+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/stopfever/overview-of-diseases/caps 2025-10-16T11:18:07+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/stopfever/overview-of-diseases/fmf 2025-10-16T11:18:08+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/stopfever/diagnostic-criteria 2025-10-16T11:18:10+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/stopfever/traps 2025-10-16T11:18:11+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/stopfever/interactive-criteria-hids 2025-10-16T11:18:12+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/stopfever/interactive-criteria-caps 2025-10-16T11:18:13+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/stopfever/interactive-criteria-fmf 2025-10-16T11:18:14+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/stopfever/clinical-guidelines 2025-10-16T11:18:17+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/stopfever/ssl 2025-10-16T11:18:17+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/stopfever/clinical-guidelines-caps 2025-10-16T11:18:19+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/stopfever/clinical-guidelines-traps 2025-10-16T11:18:20+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/stopfever/reprint 2025-10-16T11:18:21+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/stopfever/video 2025-10-16T11:18:22+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/stopfever/test 2025-10-16T12:18:08+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/stopfever/privacy 2025-10-16T11:19:32+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/stopfever/library 2025-10-16T11:18:16+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/braf/agnosticheskij-podhod-v-dejstvii 2025-10-17T09:07:39+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/braf/agnosticheskij-podhod-k-terapii-v-onkologii 2025-10-17T09:09:33+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/iptakopan/issledovanie-realnoj-klinicheskoj-praktiki-v-PNG 2025-10-17T13:13:00+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/iptakopan/klinicheskij-sluchaj-opyt-primeneniya-iptakopana-u-pacienta-s-PNG-s-suboptimalnym-otvetom 2025-10-17T13:16:00+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/iptakopan/nepryamoe-sravnitelnoe-issledovanie-effectivnosti-terapii 2025-10-17T13:18:35+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/iptakopan/osobennosti-priema 2025-10-17T13:31:51+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/iptakopan/programma-rasshirennogo-nablyudeniya-REP-PNG 2025-10-17T13:32:55+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/iptakopan/rezultaty-issledovaniya-apply-24-nedeli 2025-10-17T13:34:00+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/iptakopan/rezultaty-issledovaniya-apply-pnh-48 2025-10-17T13:35:05+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/iptakopan/rezultaty-issledovaniya-appoint-pnh-24 2025-10-17T13:36:16+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/iptakopan/rezultaty-issledovaniya-appoint-pnh-48 2025-10-17T13:37:30+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/iptakopan/rossiyski-opyt-primenenia-iptakopana 2025-10-17T13:38:32+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/adjuvant-rmj/video 2025-10-22T09:20:59+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/oncode/interactive_cases/case_1 2025-10-20T08:01:21+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/oncode/interactive_cases/case_7 2025-10-20T08:01:27+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/oncode/interactive_cases/case_8 2025-10-20T08:01:28+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/oncode/interactive_cases/case_2 2025-10-20T08:01:22+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/oncode/interactive_cases/case_14 2025-10-20T08:01:40+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/oncode/interactive_cases/case_13 2025-10-20T08:01:37+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/oncode/interactive_cases/case_12 2025-10-20T08:01:36+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/oncode/interactive_cases/case_4 2025-10-20T08:01:24+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/oncode/interactive_cases/case_3 2025-10-20T08:01:23+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/oncode/interactive_cases/case_5 2025-10-20T08:01:24+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/oncode/interactive_cases/case_9 2025-10-20T08:01:29+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/oncode/interactive_cases/case_6 2025-10-20T08:01:25+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/oncode/interactive_cases/case_11 2025-10-20T08:01:43+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/oncode/interactive_cases/case_10 2025-10-20T08:01:30+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/oncode/interactive_cases 2025-10-20T08:06:46+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/oncode/therapy_schemes 2025-10-20T08:07:35+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/melanoma-site 2025-10-20T12:37:10+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/melanoma-code 2025-12-03T09:58:23+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/melanoma-clin-case-1 2025-10-20T13:46:09+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/melanoma-clin-case-2 2025-10-20T14:02:38+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/melanoma-site-article-1 2025-10-20T12:53:20+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/melanoma-site-article-2 2025-10-20T12:53:20+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/melanoma-site-article-3 2025-10-20T12:53:22+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/melanoma-site-article-5 2025-10-20T12:53:24+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/melanoma/melanoma-site-article-4 2025-10-20T12:53:23+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/mshelper 2025-11-18T10:10:48+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/chto-my-znaem-ob-effektivnosti-ingibitorov-cdk-46-vo-vtoroy-linii-terapii-hr-her2-mrmzh 2025-11-24T12:44:25+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/iptakopan/klinicheskij-sluchaj-opyt-primeneniya-i-aspekty-prakticheskogo-primenenia-iptakopana 2025-12-16T14:05:26+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/iptakopan/klinicheskij-sluchaj-opyt-primeneniya-iptakopana-v-rf 2025-12-16T14:06:58+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/oncology/breast-cancer/webinars 2026-02-05T11:33:01+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/hematology/iptakopan/dolgosrochnaya-bezopasnost-i-effektivnost-iptakopana 2026-02-05T14:57:34+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/neurology/dementia 2026-02-26T14:31:33+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/nefrologiya/c3-glomerulopatiya 2026-03-17T12:04:12+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/nefrologiya/iga-nefropatiya 2026-03-17T12:39:24+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/nefrologiya/diagnostika 2026-03-31T06:45:05+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/therapeutical-areas/nefrologiya/terapiya 2026-03-17T12:08:40+00:00 daily 0.5 https://www.pro.novartis.com/ru-ru/sitemap.xml 2026-03-31T02:34:24+00:00